Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
19 "Sung Hye Kong"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Review Article
Mineral, bone & muscle
Incorporating Artificial Intelligence into Fracture Risk Assessment: Using Clinical Imaging to Predict the Unpredictable
Sung Hye Kong
Endocrinol Metab. 2025;40(4):499-507.   Published online August 4, 2025
DOI: https://doi.org/10.3803/EnM.2025.2518
  • 4,338 View
  • 105 Download
  • 1 Web of Science
  • 2 Crossref
AbstractAbstract PDFPubReader   ePub   
Artificial intelligence (AI) is increasingly being explored as a complementary tool to traditional fracture risk assessment methods. Conventional approaches, such as bone mineral density measurement and established clinical risk calculators, provide populationlevel stratification but often fail to capture the structural nuances of bone fragility. Recent advances in AI—particularly deep learning techniques applied to imaging—enable opportunistic screening and individualized risk estimation using routinely acquired radiographs and computed tomography (CT) data. These models demonstrate improved discrimination for osteoporotic fracture detection and risk prediction, supporting applications such as time-to-event modeling and short-term prognosis. CT- and radiograph-based models have shown superiority over conventional metrics in diverse cohorts, while innovations like multitask learning and survival plots contribute to enhanced interpretability and patient-centered communication. Nevertheless, challenges related to model generalizability, data bias, and automation bias persist. Successful clinical integration will require rigorous external validation, transparent reporting, and seamless embedding into electronic medical systems. This review summarizes recent advances in AI-driven fracture assessment, critically evaluates their clinical promise, and outlines a roadmap for translation into real-world practice.

Citations

Citations to this article as recorded by  
  • Quantitative CT Analysis for Predicting Hip Fragility Fracture Risk in Postmenopausal Women: A Value Assessment
    昭春 杜
    Advances in Clinical Medicine.2026; 16(01): 2897.     CrossRef
  • Diagnostic Value of Opportunistic CT-Based Bone Density Assessment in Patients with and Without Sacral Insufficiency Fractures
    Julian Ramin Andresen, Guido Schröder, Thomas Haider, Hans-Christof Schober, Reimer Andresen
    Diagnostics.2025; 15(22): 2926.     CrossRef
Close layer
Original Articles
Mineral, bone & muscle
Comparison of the Effectiveness and Hypocalcemia Risk of Antiresorptive Agents in Patients with Hypercalcemia of Malignancy
Sung Hye Kong, Seung Shin Park, Jung Hee Kim, Sang Wan Kim, Se Hyun Kim, Jee Hyun Kim, Chan Soo Shin
Endocrinol Metab. 2025;40(2):289-298.   Published online February 4, 2025
DOI: https://doi.org/10.3803/EnM.2024.2132
  • 3,619 View
  • 155 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Hypercalcemia of malignancy (HCM), a major metabolic complication of cancer, is often managed with bisphosphonates (BP) and, increasingly, with denosumab. We aimed to compare the effectiveness and safety of denosumab with that of BP, with or without calcitonin, in treating HCM.
Methods
This retrospective cohort study was conducted at a tertiary hospital from 2017 to 2022 and included 317 patients treated for HCM. Participants were divided into three treatment groups: denosumab, intravenous (IV) BP only, and IV BP combined with calcitonin. The primary outcomes measured were changes in calcium levels and the incidence of hypocalcemia. Analysis of covariance was used to adjust for age, sex, body mass index, creatinine level, type of malignancy, and the use of furosemide and steroids.
Results
The mean participant age was 65 years, and 37.5% were female. After adjustment, both denosumab and IV BPs were found to effectively lower calcium levels. Denosumab led to a decrease of 2.0 mg/dL (−15.9%), while IV BP alone resulted in a reduction of 1.8 mg/dL (−13.9%). The largest reduction, of 2.7 mg/dL (−20.9%), occurred with IV BP and calcitonin. Both denosumab and IV BP+calcitonin yielded their lowest calcium levels within 48 hours, whereas the IV BP only group reached a nadir within 72 hours. Despite these differences in treatment effectiveness, hypocalcemia occurred significantly less frequently in the denosumab group compared to the other groups.
Conclusion
Denosumab and IV BP were similarly effective in reducing calcium levels. However, IV BP combined with calcitonin yielded a more rapid and pronounced decrease.

Citations

Citations to this article as recorded by  
  • Denosumab

    Reactions Weekly.2025; 2067(1): 150.     CrossRef
Close layer
Adrenal gland
The Modified S-GRAS Scoring System for Prognosis in Korean with Adrenocortical Carcinoma
Sun Kyung Baek, Seung Hun Lee, Seung Shin Park, Chang Ho Ahn, Sung Hye Kong, Won Woong Kim, Yu-Mi Lee, Su Jin Kim, Dong Eun Song, Tae-Yon Sung, Kyu Eun Lee, Jung Hee Kim, Kyeong Cheon Jung, Jung-Min Koh
Endocrinol Metab. 2024;39(5):803-812.   Published online September 25, 2024
DOI: https://doi.org/10.3803/EnM.2024.2086
  • 3,279 View
  • 87 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Adrenocortical carcinomas (ACCs) are rare tumors with aggressive but varied prognosis. Stage, Grade, Resection status, Age, Symptoms (S-GRAS) score, based on clinical and pathological factors, was found to best stratify the prognosis of European ACC patients. This study assessed the prognostic performance of modified S-GRAS (mS-GRAS) scores including modified grade (mG) by integrating mitotic counts into the Ki67 index (original grade), in Korean ACC patients.
Methods
Patients who underwent surgery for ACC between January 1996 and December 2022 at three medical centers in Korea were retrospectively analyzed. mS-GRAS scores were calculated based on tumor stage, mG (Ki67 index or mitotic counts), resection status, age, and symptoms. Patients were divided into four groups (0–1, 2–3, 4–5, and 6–9 points) based on total mS-GRAS score. The associations of each variable and mS-GRAS score with recurrence and survival were evaluated using Cox regression analysis, Harrell’s concordance index (C-index), and the Kaplan–Meier method.
Results
Data on mS-GRAS components were available for 114 of the 153 patients who underwent surgery for ACC. These 114 patients had recurrence and death rates of 61.4% and 48.2%, respectively. mS-GRAS score was a significantly better predictor of recurrence (C-index=0.829) and death (C-index=0.747) than each component (P<0.05), except for resection status. mS-GRAS scores correlated with shorter progression-free survival (P=8.34E-24) and overall survival (P=2.72E-13).
Conclusion
mS-GRAS scores showed better prognostic performance than tumor stage and grade in Asian patients who underwent surgery for ACC.

Citations

Citations to this article as recorded by  
  • External validation of the S-GRAS score for predicting recurrence in patients with adrenocortical carcinoma: implications for adjuvant mitotane therapy
    Paula Jimenez-Fonseca, Cristina Álvarez-Escola, Inmaculada Ballester Navarro, Jorge Hernando Cubero, Laura González Fernández, Miguel Ángel Mangas Cruz, Clara Iglesias, Jesús García-Donas, María José Picón, Miguel Paja, Lorena González Batanero, Lourdes G
    European Journal of Endocrinology.2025; 193(2): 320.     CrossRef
Close layer
Mineral, Bone & Muscle
Big Data Articles (National Health Insurance Service Database)
Elevated Fracture Risks in Patients Using Inhaled Corticosteroids: A Korean Nationwide Study
Sung Hye Kong, Ae Jeong Jo, Chan Mi Park, Kyun Ik Park, Ji Eun Yun, Jung Hee Kim
Endocrinol Metab. 2025;40(1):82-92.   Published online August 30, 2024
DOI: https://doi.org/10.3803/EnM.2024.1990
  • 4,729 View
  • 106 Download
  • 1 Web of Science
  • 2 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
In this comprehensive retrospective nationwide cohort study, we examined the relationships between various asthma medications and bone health, utilizing data from the National Health Insurance Service database of South Korea.
Methods
From 2015 to 2019, the relevant dataset included 168,611 individuals aged 66 years, among whom 8,747 were diagnosed with asthma. We focused on a subset of 6,173 patients, all 66-year-old women. Participants were categorized into four groups: nonusers of asthma medication (n=2,868), leukotriene antagonist users (n=2,281), inhaled corticosteroid (ICS) users (n=517), and those using a combination of ICS and long-acting beta-agonist (ICS+LABA) medication (n=507). The primary outcomes measured were the incidences of major osteoporotic fractures and hip fractures during the follow-up period.
Results
Over 2.7 years of follow-up, 615 cases of major osteoporotic fractures and 96 cases of hip fractures were recorded. ICS users exhibited a heightened risk of both injuries, with hazard ratios of 1.38 (95% confidence interval [CI], 1.18 to 1.63; P<0.001) for major osteoporotic fractures and 1.56 (95% CI, 1.33 to 1.83; P<0.001) for hip fractures. Similarly elevated risks were observed in the ICS+LABA group. Notably, the risk associated with ICS was particularly pronounced among patients with osteopenia for both fracture types. Overall, the use of ICS, alone or in combination with LABA, in patients with asthma is associated with significantly increased risks of osteoporotic fractures, especially among those with osteopenia.
Conclusion
These findings underscore the importance of considering bone health when managing asthma, especially in older patients and those with existing bone density issues.

Citations

Citations to this article as recorded by  
  • Osteoporosis Awareness in Asthma Patients Using Inhaled Corticosteroids: A Cross-Sectional Study
    Gülcan Öztürk, Berrin Zinnet Eraslan, Serap Diktaş Tahtasakal, Pinar Akpınar, Duygu Silte Karamanlioglu, Feyza Ünlü Özkan, İlknur Aktaş, Sevda Cömert
    Sakarya Medical Journal.2025; 15(2): 93.     CrossRef
  • Understanding Glucocorticoid-induced Osteoporosis: Causes, Effects and Management
    Mozhdeh Ghamari, Farnoosh Ebrahimzadeh, Kamila Hashemzadeh
    Indian Journal of Rheumatology.2025;[Epub]     CrossRef
Close layer
Review Article
Mineral, Bone & Muscle
Effects of Endocrine-Disrupting Chemicals on Bone Health
So Young Park, Sung Hye Kong, Kyoung Jin Kim, Seong Hee Ahn, Namki Hong, Jeonghoon Ha, Sihoon Lee, Han Seok Choi, Ki-Hyun Baek, Jung-Eun Kim, Sang Wan Kim, on Behalf of Metabolic Bone Disease Study Group of Korean Endocrine Society
Endocrinol Metab. 2024;39(4):539-551.   Published online July 17, 2024
DOI: https://doi.org/10.3803/EnM.2024.1963
  • 9,520 View
  • 468 Download
  • 11 Web of Science
  • 12 Crossref
AbstractAbstract PDFPubReader   ePub   
This comprehensive review critically examines the detrimental impacts of endocrine-disrupting chemicals (EDCs) on bone health, with a specific focus on substances such as bisphenol A (BPA), per- and polyfluoroalkyl substances (PFASs), phthalates, and dioxins. These EDCs, by interfering with the endocrine system’s normal functioning, pose a significant risk to bone metabolism, potentially leading to a heightened susceptibility to bone-related disorders and diseases. Notably, BPA has been shown to inhibit the differentiation of osteoblasts and promote the apoptosis of osteoblasts, which results in altered bone turnover status. PFASs, known for their environmental persistence and ability to bioaccumulate in the human body, have been linked to an increased osteoporosis risk. Similarly, phthalates, which are widely used in the production of plastics, have been associated with adverse bone health outcomes, showing an inverse relationship between phthalate exposure and bone mineral density. Dioxins present a more complex picture, with research findings suggesting both potential benefits and adverse effects on bone structure and density, depending on factors such as the timing and level of exposure. This review underscores the urgent need for further research to better understand the specific pathways through which EDCs affect bone health and to develop targeted strategies for mitigating their potentially harmful impacts.

Citations

Citations to this article as recorded by  
  • Bile acids insufficiency links perfluorooctane sulfonate-induced oxidative stress-mediated fatty liver with osteoarthritis
    Jialing Yu, Sihan Huang, Jianbin Zhang, Zijian Su, Yiming Chang, Keke Liu, Lu Yang, Huiying Guo, Jinshao Ye, Xujing Liang, Xiaojia Chen, An Hong, Yibo Zhang
    Journal of Hazardous Materials.2026; 501: 140750.     CrossRef
  • Unraveling the Mechanisms of Osteoporosis Triggered by Methylparaben and Monomethyl Phthalate through Integrated Mendelian Randomization, In Silico Simulations, and Experimental Validation
    Hailong Liu, Xin Xu, Longzhuo Du, Wencan Zhang, Yongyuan Guo, Fujian Zhang, Houyi Sun, Haipeng Si, Peilai Liu
    Environmental Science & Technology.2026; 60(1): 228.     CrossRef
  • One-step synthesis of porous chlorine-modified graphitic carbon nitrides for efficient photocatalytic degradation of bisphenol A: DFT insights and mechanistic pathways under visible light
    Yun-Cheng Mei, Tesfaye Abebe Geleta, Ashkan Miri, Prashanth Venkatesan, Yu-Chiang Chao, Yutong Chen, Pei-Hsin Chou, Ren Qian Tee, Yang-hsin Shih
    Journal of Environmental Chemical Engineering.2026; 14(1): 121018.     CrossRef
  • Effects of Endocrine Disruptors on the Molecular Regulation of Bone Metabolism: Wnt/β-Catenin Signaling Pathway
    Deren KAYA, Rabia ŞEMSİ
    FUTURE BIOCHEMISTRY AND BIOSCIENCE.2026; : 1.     CrossRef
  • Elucidating the mechanism of phthalates induced osteoporosis through network toxicology and molecular docking
    Xiao Zhang, Xi Zhu, Wenbo Gu, Xusheng Li, Tenyao Niu, Pengcheng Mao, Haifeng Yuan
    Ecotoxicology and Environmental Safety.2025; 291: 117820.     CrossRef
  • Exposure to polycyclic aromatic hydrocarbons and bone mineral density in children and adolescents: results from the 2011–2016 National Health and Nutrition Examination Survey
    Peng Zhang, Shuailei Li, Hao Zeng, Yongqiang Sun
    Frontiers in Public Health.2025;[Epub]     CrossRef
  • Harmful beauty – Temporal profile of urinary phthalate metabolites in tattooed volunteers from Slovakia
    Branislav Kolena, Natália Prochácková, Henrieta Hlisníková, Miroslava Nagyová, Ida Petrovičová
    Toxicology Letters.2025; 410: 96.     CrossRef
  • Integrated PBPK modelling for PFOA exposure and risk assessment
    Achilleas Karakoltzidis, Spyros P. Karakitsios, Catherine Gabriel, Dimosthenis Α. Sarigiannis
    Environmental Research.2025; 282: 121947.     CrossRef
  • Associations of urinary organophosphate ester metabolites with bone mineral density in U.S. children and adolescents aged 8–19 years: a cross-sectional study based on NHANES 2011–2018
    Hongliang Jin, Xinyun Zhou, Xinyue Wang, Yan Zhang
    European Journal of Pediatrics.2025;[Epub]     CrossRef
  • Non-linear associations between exposure to a mixture of per- and polyfluoroalkyl substances and thyroid hormone levels in Korean adults
    Seung Min Chung, Ji-Hyeon Cha, Young-Heun Jung, Ju-Hyun Kim, Jun Sung Moon, Kyu Chang Won
    Environment International.2025; 201: 109585.     CrossRef
  • Citizen Science in Action: Preliminary Observations on Bat Box Use in the Perth and Peel Regions, Western Australia
    Kelly Sheldrick, Kelly Duckworth
    Journal of The Royal Society of Western Australia.2025;[Epub]     CrossRef
  • Comment on “Standardized gynecologic consultation and bone surveillance in patients with breast cancer receiving hormone therapy”2
    Rachana Mehta, Ranjana Sah
    Supportive Care in Cancer.2025;[Epub]     CrossRef
Close layer
Editorial
Mineral, Bone & Muscle
Insights from Decades of Supplementing Calcium and Vitamin D
Sung Hye Kong
Endocrinol Metab. 2024;39(3):445-447.   Published online May 23, 2024
DOI: https://doi.org/10.3803/EnM.2024.2016
  • 4,271 View
  • 124 Download
  • 1 Web of Science
  • 1 Crossref
PDFPubReader   ePub   

Citations

Citations to this article as recorded by  
  • Total Thyroidectomy: Resection of Two Organs, Not Just One
    Erhan Aysan
    Endocrinology and Metabolism.2024; 39(5): 696.     CrossRef
Close layer
Brief Report
Diabetes, obesity and metabolism
Ketonuria as an Indicator of Improvement of Renal Function in Patients with Type 2 Diabetes Receiving SGLT2 Inhibitor Treatment
Hyun Ah Kim, Han Na Jang, Sung Hye Kong, Young Lee, Sung Hee Choi, Young Min Cho, Hak Chul Jang, Tae Jung Oh
Endocrinol Metab. 2024;39(4):653-658.   Published online May 16, 2024
DOI: https://doi.org/10.3803/EnM.2024.1919
  • 5,518 View
  • 156 Download
  • 3 Web of Science
  • 3 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
We investigated the potential association between ketonuria during treatment with sodium-glucose cotransporter-2 (SGLT2) inhibitors and its renoprotective effect in patients with type 2 diabetes. We included 192 patients who had received SGLT2 inhibitors for more than 6 months. After propensity score matching, 52 patients each were allocated into groups with or without ketonuria, respectively. The estimated glomerular filtration rate exhibited a significant improvement only in subjects with ketonuria (without ketonuria: mean difference, –0.02 mL/min/1.73 m2 [95% confidence interval (CI), –3.87 to 3.83 mL/min/1.73 m2] vs. with ketonuria: mean difference, 6.81 mL/min/1.73 m2 [95% CI, 3.16 to 10.46 mL/min/1.73 m2]; P<0.001). Improvement in estimated glomerular filtration rate at 6 months was associated with female sex and lower baseline body weight, blood pressure, and triglyceride levels in patients with ketonuria. In conclusion, the presence of ketonuria was associated with the renoprotective effect of SGLT2 inhibitors, and female sex and the absence of metabolic syndrome components may serve as additional indicators of these medications’ substantial renoprotective effects in individuals with ketonuria.

Citations

Citations to this article as recorded by  
  • Effects of a continuous remote care intervention including nutritional ketosis on kidney function and inflammation in adults with type 2 diabetes: a post-hoc latent class trajectory analysis
    Shaminie J. Athinarayanan, Caroline G. P. Roberts, Stephen D. Phinney, Thomas Weimbs, Allon N. Friedman, Jeff S. Volek
    Frontiers in Nutrition.2025;[Epub]     CrossRef
  • SGLT2 Inhibitors as Systemic Metabolic Modulators: Linking Glucose Excretion to Liver Function Restoration
    Seung Wan Noh, Han Sol Ryu, Yong-Ho Kim, Byung-Chul Oh
    Endocrinology and Metabolism.2025; 40(6): 851.     CrossRef
  • Trigger Warning: How Modern Diet, Lifestyle, and Environment Pull the Trigger on Autosomal Dominant Polycystic Kidney Disease Progression
    Melina Messing, Jacob A. Torres, Nickolas Holznecht, Thomas Weimbs
    Nutrients.2024; 16(19): 3281.     CrossRef
Close layer
Review Article
Mineral, Bone & Muscle
Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations
Kyoung Jin Kim, Jeonghoon Ha, Sang Wan Kim, Jung-Eun Kim, Sihoon Lee, Han Seok Choi, Namki Hong, Sung Hye Kong, Seong Hee Ahn, So Young Park, Ki-Hyun Baek, on Behalf of Metabolic Bone Disease Study Group of Korean Endocrine Society
Endocrinol Metab. 2024;39(2):267-282.   Published online April 25, 2024
DOI: https://doi.org/10.3803/EnM.2024.1939
  • 13,200 View
  • 458 Download
  • 11 Web of Science
  • 11 Crossref
AbstractAbstract PDFPubReader   ePub   
This review article investigates solid organ transplantation-induced osteoporosis, a critical yet often overlooked issue, emphasizing its significance in post-transplant care. The initial sections provide a comprehensive understanding of the prevalence and multifactorial pathogenesis of transplantation osteoporosis, including factors such as deteriorating post-transplantation health, hormonal changes, and the impact of immunosuppressive medications. Furthermore, the review is dedicated to organ-specific considerations in transplantation osteoporosis, with separate analyses for kidney, liver, heart, and lung transplantations. Each section elucidates the unique challenges and management strategies pertinent to transplantation osteoporosis in relation to each organ type, highlighting the necessity of an organ-specific approach to fully understand the diverse manifestations and implications of transplantation osteoporosis. This review underscores the importance of this topic in transplant medicine, aiming to enhance awareness and knowledge among clinicians and researchers. By comprehensively examining transplantation osteoporosis, this study contributes to the development of improved management and care strategies, ultimately leading to improved patient outcomes in this vulnerable group. This detailed review serves as an essential resource for those involved in the complex multidisciplinary care of transplant recipients.

Citations

Citations to this article as recorded by  
  • Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement
    John R. Greenland, Michael Perch, Kieran Halloran, Deborah J. Levine, Eric D. Morrell, Anna Reed, Ciara M. Shaver, Jonathan P. Singer, Stuart C. Sweet, Robin Vos, Shambhu Aryal, Nicholas Avdimiretz, Fay Burrows, Daniel Calabrese, Fiorella Calabrese, Silvi
    The Journal of Heart and Lung Transplantation.2026; 45(2): e104.     CrossRef
  • The immunobiology and therapeutic potential of regulatory T cells in autoimmune diseases and allergic diseases
    Wen-Wen Xie, Jian-Bin Huang, Yi-Chi Zhou, Jing-Yi Yuan, Jia-Xue Feng, Xiao-Hang Shi, Li Tian, Xian-Hai Zeng, Shu-Qi Qiu, Mei-Zhen Zhao, Bao-Hui Cheng, Hao-Tao Zeng
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • Osteoporosis After Menopause and After Drug Therapy: The Molecular Mechanism of Bone Loss and Its Treatment
    Kelly I-Rong Lee, Jie-Hong Chen, Kuo-Hu Chen
    International Journal of Molecular Sciences.2026; 27(2): 641.     CrossRef
  • Romosozumab as Treatment for Severe Osteoporosis in Heart and Lung Transplant Recipients
    Lisa M. Raven, Jacqueline R. Center, Christopher A. Muir
    Endocrines.2025; 6(1): 2.     CrossRef
  • Side Effects of Immunosuppressant Drugs After Liver Transplant
    Filippo Gabrielli, Elisa Bernasconi, Arianna Toscano, Alessandra Avossa, Alessia Cavicchioli, Pietro Andreone, Stefano Gitto
    Pharmaceuticals.2025; 18(3): 342.     CrossRef
  • Exploiting regulatory T cells (Tregs): Cutting-edge therapy for autoimmune diseases
    Marwa Hassan, Mohamed Elzallat, Dina Mostafa Mohammed, Mahmoud Balata, Walaa H. El-Maadawy
    International Immunopharmacology.2025; 155: 114624.     CrossRef
  • Results of the implementation of a multidisciplinary care protocol for preventing fragility fractures following liver transplantation
    A. Monegal, J. L. Carrasco, P. Peris, B. Frade-Sosa, A. Azuaga, H. Florez, A. Dura, N. Guañabens, J. Colmenero
    Osteoporosis International.2025; 36(7): 1213.     CrossRef
  • Treatment of osteoporosis in the solid organ transplant recipient: an organ-based approach
    Soumya Kurnool, Nandi Shah, Preethika Ekanayake
    Therapeutic Advances in Endocrinology and Metabolism.2025;[Epub]     CrossRef
  • Global and regional prevalence of osteoporosis in kidney transplant recipients: a systematic review and meta-analysis
    Mobin Ghazaiean, Tahoora Mousavi, Mahmood Moosazadeh
    Clinical and Experimental Medicine.2025;[Epub]     CrossRef
  • Endocrine effects of long-term calcineurin inhibitor use in solid organ transplant recipients
    Talia Diker Cohen, Idit Dotan, Bronya Calvarysky, Eyal Robenshtok
    European Journal of Endocrinology.2025; 193(3): R1.     CrossRef
  • Bone disease in kidney transplant: don’t forget about osteomalacia: a case report and literature review
    Francesco Aguanno, Alessia Passaseo, Simona Barbuto, Daniele Vetrano, Guido Zavatta, Guido Marzocchi, Sandro Giannini, Giorgia Comai, Gaetano La Manna, Giuseppe Cianciolo
    International Urology and Nephrology.2025;[Epub]     CrossRef
Close layer
Original Articles
Mineral, Bone & Muscle
Protein Signatures of Parathyroid Adenoma according to Tumor Volume and Functionality
Sung Hye Kong, Jeong Mo Bae, Jung Hee Kim, Sang Wan Kim, Dohyun Han, Chan Soo Shin
Endocrinol Metab. 2024;39(2):375-386.   Published online March 21, 2024
DOI: https://doi.org/10.3803/EnM.2023.1827
  • 4,926 View
  • 83 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Parathyroid adenoma (PA) is a common endocrine disease linked to multiple complications, but the pathophysiology of the disease remains incompletely understood. The study aimed to identify the key regulator proteins and pathways of PA according to functionality and volume through quantitative proteomic analyses.
Methods
We conducted a retrospective study of 15 formalin-fixed, paraffin-embedded PA samples from tertiary hospitals in South Korea. Proteins were extracted, digested, and the resulting peptides were analyzed using liquid chromatography-tandem mass spectrometry. Pearson correlation analysis was employed to identify proteins significantly correlated with clinical variables. Canonical pathways and transcription factors were analyzed using Ingenuity Pathway Analysis.
Results
The median age of the participants was 52 years, and 60.0% were female. Among the 8,153 protein groups analyzed, 496 showed significant positive correlations with adenoma volume, while 431 proteins were significantly correlated with parathyroid hormone (PTH) levels. The proteins SLC12A9, LGALS3, and CARM1 were positively correlated with adenoma volume, while HSP90AB2P, HLA-DRA, and SCD5 showed negative correlations. DCPS, IRF2BPL, and FAM98A were the main proteins that exhibited positive correlations with PTH levels, and SLITRK4, LAP3, and AP4E1 had negative correlations. Canonical pathway analysis demonstrated that the RAN and sirtuin signaling pathways were positively correlated with both PTH levels and adenoma volume, while epithelial adherence junction pathways had negative correlations.
Conclusion
Our study identified pivotal proteins and pathways associated with PA, offering potential therapeutic targets. These findings accentuate the importance of proteomics in understanding disease pathophysiology and the need for further research.

Citations

Citations to this article as recorded by  
  • Aberrant Histone Methylation Profile in Patients with Sporadic Primary Hyperparathyroidism
    Poonam Kumari, Sanjay Kumar Bhadada, Ashutosh Kumar Arya, Jyotdeep Kaur, Naresh Sachdeva, Uma Nahar Saikia, Divya Dahiya, Anoop Kumar, Chirag Kharbanda, Sudhaker D Rao
    The Journal of Clinical Endocrinology & Metabolism.2025;[Epub]     CrossRef
Close layer
Mineral, Bone & Muscle
Development of a Spine X-Ray-Based Fracture Prediction Model Using a Deep Learning Algorithm
Sung Hye Kong, Jae-Won Lee, Byeong Uk Bae, Jin Kyeong Sung, Kyu Hwan Jung, Jung Hee Kim, Chan Soo Shin
Endocrinol Metab. 2022;37(4):674-683.   Published online August 5, 2022
DOI: https://doi.org/10.3803/EnM.2022.1461
  • 10,030 View
  • 312 Download
  • 34 Web of Science
  • 34 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Since image-based fracture prediction models using deep learning are lacking, we aimed to develop an X-ray-based fracture prediction model using deep learning with longitudinal data.
Methods
This study included 1,595 participants aged 50 to 75 years with at least two lumbosacral radiographs without baseline fractures from 2010 to 2015 at Seoul National University Hospital. Positive and negative cases were defined according to whether vertebral fractures developed during follow-up. The cases were divided into training (n=1,416) and test (n=179) sets. A convolutional neural network (CNN)-based prediction algorithm, DeepSurv, was trained with images and baseline clinical information (age, sex, body mass index, glucocorticoid use, and secondary osteoporosis). The concordance index (C-index) was used to compare performance between DeepSurv and the Fracture Risk Assessment Tool (FRAX) and Cox proportional hazard (CoxPH) models.
Results
Of the total participants, 1,188 (74.4%) were women, and the mean age was 60.5 years. During a mean follow-up period of 40.7 months, vertebral fractures occurred in 7.5% (120/1,595) of participants. In the test set, when DeepSurv learned with images and clinical features, it showed higher performance than FRAX and CoxPH in terms of C-index values (DeepSurv, 0.612; 95% confidence interval [CI], 0.571 to 0.653; FRAX, 0.547; CoxPH, 0.594; 95% CI, 0.552 to 0.555). Notably, the DeepSurv method without clinical features had a higher C-index (0.614; 95% CI, 0.572 to 0.656) than that of FRAX in women.
Conclusion
DeepSurv, a CNN-based prediction algorithm using baseline image and clinical information, outperformed the FRAX and CoxPH models in predicting osteoporotic fracture from spine radiographs in a longitudinal cohort.

Citations

Citations to this article as recorded by  
  • Artificial intelligence and multimodal imaging in orthopaedics: from technological advances to clinical translation
    Guangan Luo, Shuanglong Tan, Lincong Luo, Konghe Hu
    Frontiers in Medicine.2026;[Epub]     CrossRef
  • Artificial Intelligence in Rheumatology: From Algorithms to Clinical Impact in Osteoporosis and Chronic Inflammatory Rheumatic Diseases
    Marie Doussiere, Ahlem Aboud, Gilles Dequen, Vincent Goëb
    Journal of Clinical Medicine.2026; 15(2): 491.     CrossRef
  • Deep learning for hepatocellular carcinoma recurrence before and after liver transplantation: a multicenter cohort study
    Shuang Cao, Sihan Yu, Liangbin Huang, Samuel Seery, Yu Xia, Yongwei Zhao, Zhongzhou Si, Xinxue Zhang, Jiqiao Zhu, Ren Lang, Jiantao Kou, Haiming Zhang, Lin Wei, Guangpeng Zhou, Liying Sun, Lei Wang, Ting Li, Qiang He, Zhijun Zhu
    Scientific Reports.2025;[Epub]     CrossRef
  • Accuracy of artificial intelligence in prediction of osteoporotic fractures in comparison with dual-energy X-ray absorptiometry and the Fracture Risk Assessment Tool: A systematic review
    Mir Sadat-Ali, Bandar A Alzahrani, Turki S Alqahtani, Musaad A Alotaibi, Abdallah M Alhalafi, Ahmed A Alsousi, Abdullah M Alasiri
    World Journal of Orthopedics.2025;[Epub]     CrossRef
  • Deep learning-based identification of vertebral fracture and osteoporosis in lateral spine radiographs and DXA vertebral fracture assessment to predict incident fracture
    Namki Hong, Sang Wouk Cho, Young Han Lee, Chang Oh Kim, Hyeon Chang Kim, Yumie Rhee, William D Leslie, Steven R Cummings, Kyoung Min Kim
    Journal of Bone and Mineral Research.2025; 40(5): 628.     CrossRef
  • Aplicaciones de aprendizaje profundo en ortopedia: una revisión sistemática y futuras direcciones
    R González-Pola, A Herrera-Lozano, LF Graham-Nieto, G Zermeño-García
    Acta Ortopédica Mexicana.2025; 39(3): 152.     CrossRef
  • A Federated Graph-Based Multimodal AI Framework for Privacy-Preserving and Explainable Osteoporosis Detection
    O. Venkata Siva, M. S. Anbarasi
    International Journal on Artificial Intelligence Tools.2025;[Epub]     CrossRef
  • Artificial Intelligence for Bone: Theory, Methods, and Applications
    Dongfeng Yuan, Haicang Zhang, Liping Tong, Di Chen
    Advanced Intelligent Discovery.2025;[Epub]     CrossRef
  • Incorporating Artificial Intelligence into Fracture Risk Assessment: Using Clinical Imaging to Predict the Unpredictable
    Sung Hye Kong
    Endocrinology and Metabolism.2025; 40(4): 499.     CrossRef
  • Hotspots and Trends in the Application of Artificial Intelligence in Spine Medicine from 2005 to 2024: A Bibliometric and Visualization Analysis
    Tianyu Liu, Hanlin Zou, Haibo Zou
    Indian Journal of Orthopaedics.2025;[Epub]     CrossRef
  • Enhancing vertebral fracture prediction using multitask deep learning computed tomography imaging of bone and muscle
    Sung Hye Kong, Saemee Choi, Wonwoo Cho, Sung Bae Park, Seung Shin Park, Jaegul Choo, Jung Hee Kim, Sang Wan Kim, Chan Soo Shin
    European Radiology.2025;[Epub]     CrossRef
  • Artificial Intelligence Applications in Osteoporosis: A Comprehensive Review of Screening, Diagnosis, and Risk Prediction
    Alireza Keshtkar, Alireza Karimi, Farnaz Atighi, Parsa Yazdanpanahi, Arzhang Naseri, Amirhossein Khajepour, Mohammad Salehi, Yaser Sarikhani, Mohammad Hossein Dabbaghmanesh
    Shiraz E-Medical Journal.2025;[Epub]     CrossRef
  • Automated detection of vertebral fractures from X-ray images: A novel machine learning model and survey of the field
    Li-Wei Cheng, Hsin-Hung Chou, Yu-Xuan Cai, Kuo-Yuan Huang, Chin-Chiang Hsieh, Po-Lun Chu, I-Szu Cheng, Sun-Yuan Hsieh
    Neurocomputing.2024; 566: 126946.     CrossRef
  • Application of radiomics model based on lumbar computed tomography in diagnosis of elderly osteoporosis
    Baisen Chen, Jiaming Cui, Chaochen Li, Pengjun Xu, Guanhua Xu, Jiawei Jiang, Pengfei Xue, Yuyu Sun, Zhiming Cui
    Journal of Orthopaedic Research.2024; 42(6): 1356.     CrossRef
  • Machine Learning and Deep Learning in Spinal Injury: A Narrative Review of Algorithms in Diagnosis and Prognosis
    Satoshi Maki, Takeo Furuya, Masahiro Inoue, Yasuhiro Shiga, Kazuhide Inage, Yawara Eguchi, Sumihisa Orita, Seiji Ohtori
    Journal of Clinical Medicine.2024; 13(3): 705.     CrossRef
  • A CT-based Deep Learning Model for Predicting Subsequent Fracture Risk in Patients with Hip Fracture
    Yisak Kim, Young-Gon Kim, Jung-Wee Park, Byung Woo Kim, Youmin Shin, Sung Hye Kong, Jung Hee Kim, Young-Kyun Lee, Sang Wan Kim, Chan Soo Shin
    Radiology.2024;[Epub]     CrossRef
  • A Computed Tomography–Based Fracture Prediction Model With Images of Vertebral Bones and Muscles by Employing Deep Learning: Development and Validation Study
    Sung Hye Kong, Wonwoo Cho, Sung Bae Park, Jaegul Choo, Jung Hee Kim, Sang Wan Kim, Chan Soo Shin
    Journal of Medical Internet Research.2024; 26: e48535.     CrossRef
  • A Novel QCT-Based Deep Transfer Learning Approach for Predicting Stiffness Tensor of Trabecular Bone Cubes
    Pengwei Xiao, Tinghe Zhang, Yufei Huang, Xiaodu Wang
    IRBM.2024; 45(2): 100831.     CrossRef
  • Deep learning in the radiologic diagnosis of osteoporosis: a literature review
    Yu He, Jiaxi Lin, Shiqi Zhu, Jinzhou Zhu, Zhonghua Xu
    Journal of International Medical Research.2024;[Epub]     CrossRef
  • Pathological Priors Inspired Network for Vertebral Osteophytes Recognition
    Junzhang Huang, Xiongfeng Zhu, Ziyang Chen, Guoye Lin, Meiyan Huang, Qianjin Feng
    IEEE Transactions on Medical Imaging.2024; 43(7): 2522.     CrossRef
  • Fully Automatic Deep Learning Model for Spine Refracture in Patients with OVCF: A Multi‐Center Study
    Xuetao Zhu, Dejian Liu, Lian Liu, Jingxuan Guo, Zedi Li, Yixiang Zhao, Tianhao Wu, Kaiwen Liu, Xinyu Liu, Xin Pan, Lei Qi, Yuanqiang Zhang, Lei Cheng, Bin Chen
    Orthopaedic Surgery.2024; 16(8): 2052.     CrossRef
  • Artificial Intelligence in Spinal Imaging and Patient Care: A Review of Recent Advances
    Sungwon Lee, Joon-Yong Jung, Akaworn Mahatthanatrakul, Jin-Sung Kim
    Neurospine.2024; 21(2): 474.     CrossRef
  • Machine learning value in the diagnosis of vertebral fractures: A systematic review and meta-analysis
    Yue Li, Zhuang Liang, Yingchun Li, Yang Cao, Hui Zhang, Bo Dong
    European Journal of Radiology.2024; 181: 111714.     CrossRef
  • Development and reporting of artificial intelligence in osteoporosis management
    Guillaume Gatineau, Enisa Shevroja, Colin Vendrami, Elena Gonzalez-Rodriguez, William D Leslie, Olivier Lamy, Didier Hans
    Journal of Bone and Mineral Research.2024; 39(11): 1553.     CrossRef
  • Artificial intelligence in risk prediction and diagnosis of vertebral fractures
    Srikar R. Namireddy, Saran S. Gill, Amaan Peerbhai, Abith G. Kamath, Daniele S. C. Ramsay, Hariharan Subbiah Ponniah, Ahmed Salih, Dragan Jankovic, Darius Kalasauskas, Jonathan Neuhoff, Andreas Kramer, Salvatore Russo, Santhosh G. Thavarajasingam
    Scientific Reports.2024;[Epub]     CrossRef
  • Development and Validation of a Convolutional Neural Network Model to Predict a Pathologic Fracture in the Proximal Femur Using Abdomen and Pelvis CT Images of Patients With Advanced Cancer
    Min Wook Joo, Taehoon Ko, Min Seob Kim, Yong-Suk Lee, Seung Han Shin, Yang-Guk Chung, Hong Kwon Lee
    Clinical Orthopaedics & Related Research.2023; 481(11): 2247.     CrossRef
  • Automated Opportunistic Trabecular Volumetric Bone Mineral Density Extraction Outperforms Manual Measurements for the Prediction of Vertebral Fractures in Routine CT
    Sophia S. Goller, Jon F. Rischewski, Thomas Liebig, Jens Ricke, Sebastian Siller, Vanessa F. Schmidt, Robert Stahl, Julian Kulozik, Thomas Baum, Jan S. Kirschke, Sarah C. Foreman, Alexandra S. Gersing
    Diagnostics.2023; 13(12): 2119.     CrossRef
  • Machine learning‐based prediction of osteoporosis in postmenopausal women with clinical examined features: A quantitative clinical study
    Kainat A. Ullah, Faisal Rehman, Muhammad Anwar, Muhammad Faheem, Naveed Riaz
    Health Science Reports.2023;[Epub]     CrossRef
  • Skeletal Fracture Detection with Deep Learning: A Comprehensive Review
    Zhihao Su, Afzan Adam, Mohammad Faidzul Nasrudin, Masri Ayob, Gauthamen Punganan
    Diagnostics.2023; 13(20): 3245.     CrossRef
  • Deep learning system for automated detection of posterior ligamentous complex injury in patients with thoracolumbar fracture on MRI
    Sang Won Jo, Eun Kyung Khil, Kyoung Yeon Lee, Il Choi, Yu Sung Yoon, Jang Gyu Cha, Jae Hyeok Lee, Hyunggi Kim, Sun Yeop Lee
    Scientific Reports.2023;[Epub]     CrossRef
  • Vertebra Segmentation Based Vertebral Compression Fracture Determination from Reconstructed Spine X-Ray Images
    Srinivasa Rao Gadu, Chandra Sekhar Potala
    International Journal of Electrical and Electronics Research.2023; 11(4): 1225.     CrossRef
  • Computer Vision in Osteoporotic Vertebral Fracture Risk Prediction: A Systematic Review
    Anthony K. Allam, Adrish Anand, Alex R. Flores, Alexander E. Ropper
    Neurospine.2023; 20(4): 1112.     CrossRef
  • A Meaningful Journey to Predict Fractures with Deep Learning
    Jeonghoon Ha
    Endocrinology and Metabolism.2022; 37(4): 617.     CrossRef
  • New Horizons: Artificial Intelligence Tools for Managing Osteoporosis
    Hans Peter Dimai
    The Journal of Clinical Endocrinology & Metabolism.2022;[Epub]     CrossRef
Close layer
Mineral, Bone & Muscle
Effect of Vitamin D Supplementation on Risk of Fractures and Falls According to Dosage and Interval: A Meta-Analysis
Sung Hye Kong, Han Na Jang, Jung Hee Kim, Sang Wan Kim, Chan Soo Shin
Endocrinol Metab. 2022;37(2):344-358.   Published online April 25, 2022
DOI: https://doi.org/10.3803/EnM.2021.1374
  • 21,681 View
  • 505 Download
  • 37 Web of Science
  • 45 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Although recent studies comparing various dosages and intervals of vitamin D supplementation have been published, it is yet to be elucidated whether there is an appropriate dose or interval to provide benefit regarding fracture risk. We aimed to assess the published evidence available to date regarding the putative beneficial effects of vitamin D supplements on fractures and falls according to various dosages and intervals.
Methods
We performed a meta-analysis of randomized controlled studies reporting associations between vitamin D supplementation and the risks of fractures and falls in PubMed, EMBASE, and Cochrane library. Studies with supplements of ergocalciferol or calcitriol, those with a number of event ≤10, or those with a follow-up duration of less than 6 months were also excluded.
Results
Thirty-two studies were included in the final analysis. Vitamin D supplementation with daily dose of 800 to 1,000 mg was associated with lower risks of osteoporotic fracture and fall (pooled relative risk [RR], 0.87; 95% confidence interval [CI], 0.78 to 0.97 and RR, 0.91; 95% CI, 0.85 to 0.98), while studies with <800 or >1,000 mg/day did not. Also, among intervals, daily administration of vitamin D was associated with the reduced risk of falls, while intermittent dose was not. Also, patients with vitamin D deficiency showed a significant risk reduction of falls after vitamin D supplementation.
Conclusion
Daily vitamin D dose of 800 to 1,000 IU was the most probable way to reduce the fracture and fall risk. Further studies designed with various regimens and targeted vitamin D levels are required to elucidate the benefits of vitamin D supplements.

Citations

Citations to this article as recorded by  
  • The Effect of Vitamin D3 Supplementation on the Risk of Falls in a General Population—The Finnish Vitamin D Trial
    Toni Rikkonen, Sari Hantunen, Heikki Kröger, Christel Lamberg‐Allardt, JoAnn E. Manson, Tarja Nurmi, Marjo Tuppurainen, Ari Voutilainen, Tomi‐Pekka Tuomainen, Jyrki K. Virtanen
    Journal of the American Geriatrics Society.2026;[Epub]     CrossRef
  • Daily or intermittent vitamin D supplementation in patients with or at risk of osteoporosis: Position statement from the GRIO
    Marie-Eva Pickering, Jean-Claude Souberbielle, Anne Boutten, Véronique Breuil, Karine Briot, Roland Chapurlat, Patrice Fardellone, Rose-Marie Javier, Eugénie Koumakis, Bernard Cortet
    Joint Bone Spine.2025; 92(3): 105858.     CrossRef
  • Hip Fracture Patterns Among Hispanic Seniors: Risk Factors and Implications
    Nikhil Mathur, John Knight, Monica Betancourt-Garcia, Gregery Pequeno, Michael Serra-Torres
    Cureus.2025;[Epub]     CrossRef
  • Clinical efficacy of vitamin D in the prevention of osteoporosis and fractures in elderly patients
    K.K. Kurbanova, A.A. Kovaleva, A.V. Akopyan, D.M. Rak, A.S. Shuliakova
    Russian Journal of Preventive Medicine.2025; 28(5): 103.     CrossRef
  • Bone Health in Women
    Brenna Gibbons, Julia Lubsen, Andrea Ildiko Martonffy
    Primary Care: Clinics in Office Practice.2025; 52(2): 353.     CrossRef
  • ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease
    Ashwani K. Singal, Robert J. Wong, Srinivasan Dasarathy, Manal F. Abdelmalek, Brent A. Neuschwander-Tetri, Berkeley N. Limketkai, Jessica Petrey, Craig J. McClain
    American Journal of Gastroenterology.2025; 120(5): 950.     CrossRef
  • Significance of Vitamins in Health Promotion and Disease Prevention
    Kiyoshi Tanaka, Akiko Kuwabara, Misora Ao, Hiroaki Kanouchi
    The Japanese Journal of Nutrition and Dietetics.2025; 83(3): 87.     CrossRef
  • Supplémentation quotidienne ou intermittente en vitamine D chez les personnes avec ou à risque d’ostéoporose : position du GRIO
    Marie-Eva Pickering, Jean-Claude Souberbielle, Anne Boutten, Véronique Breuil, Karine Briot, Roland Chapurlat, Patrice Fardellone, Rose-Marie Javier, Eugénie Koumakis, Bernard Cortet
    Revue du Rhumatisme.2025;[Epub]     CrossRef
  • Advances in the management of osteoporosis
    Caroline Wei Shan Hoong, Dominik Saul, Sundeep Khosla, Jad G Sfeir
    BMJ.2025; 390: e081250.     CrossRef
  • The role of vitamin D in fracture healing: Insights from basic science, clinical studies, and future directions
    Jacob M. Johnson, Simbarashe J. Peresuh, Manjot Singh, Jeffrey Okewunmi, Michel A. Arcand, Joseph A. Gil
    Journal of Orthopaedic Reports.2025; : 100759.     CrossRef
  • Efficacy of Vitamin D Supplementation on the Risk of Falls Among Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis
    Raquel Torres-Lopez, Núria Obradors, Roberto Elosua, Rafael Azagra-Ledesma, Marta Zwart
    Journal of Clinical Medicine.2025; 14(17): 6117.     CrossRef
  • Vitamin D, muscle strength and function in South Asian women aged ≥ 60 years living in the North of England: a cross-sectional observational study
    Sabeen Zahra, Fraser Wiggins, Bernard M. Corfe, Elizabeth A. Williams
    European Journal of Nutrition.2025;[Epub]     CrossRef
  • Association Between Herpes Zoster and Risk of Incident Fragility Fractures in US Veterans: A Matched Cohort Study
    Calif A. A. Yousuf, Julie A. Womack, Roger J. Bedimo, Christopher T. Rentsch, Charlotte Warren‐Gash
    Journal of the American Geriatrics Society.2025; 73(12): 3778.     CrossRef
  • Beyond bones: Revisiting the role of vitamin D in chronic liver disease
    Rodrigo Guerrero-Guerrero, Osvely Mendez-Guerrero, Anaisa Carranza-Carrasco, Farid Tejeda, Astrid Ardon-Lopez, Nalu Navarro-Alvarez
    World Journal of Hepatology.2025;[Epub]     CrossRef
  • Nutrition and Liver Disease
    Allison Franz, Henry Shay, Irina Kirpich, Craig J. McClain
    Seminars in Liver Disease.2025;[Epub]     CrossRef
  • Socio-Demographic, Environmental, and Clinical Factors Influencing Osteoporosis Control in Community Pharmacies of Lahore Pakistan
    Muhammad Zahid Iqbal, Aqsa Malik, Naeem Mubarak, Tahneem Yaseen, Seerat Shahzad, Khalid M. Orayj, Saad S. Alqahtani
    Healthcare.2025; 13(24): 3291.     CrossRef
  • Vitamin D in Endocrine Disorders: A Broad Overview of Evidence in Musculoskeletal, Thyroid, Parathyroid, and Reproductive Disorders
    Balazs Lengyel, Richard Armos, Bence Bojtor, Andras Kiss, Balint Tobias, Henriett Piko, Anett Illes, Eszter Horvath, Zsuzsanna Putz, Istvan Takacs, Janos P. Kosa, Peter Lakatos
    Pharmaceuticals.2025; 19(1): 54.     CrossRef
  • Association Between Vitamin D Deficiency and Bone Mineral Density in Type 2 Diabetes: A cross-sectional study
    Waleed Arshad, Muzna Kashif, Malik faraz Ahmad
    DEVELOPMENTAL MEDICO-LIFE-SCIENCES.2025; 2(8): 27.     CrossRef
  • Ukrainian Consensus on Diagnosis and Management of Vitamin D Deficiency in Adults
    Nataliia Grygorieva, Mykola Tronko, Volodymir Kovalenko, Serhiy Komisarenko, Tetiana Tatarchuk, Ninel Dedukh, Mykola Veliky, Serhiy Strafun, Yulia Komisarenko, Andrii Kalashnikov, Valeria Orlenko, Volodymyr Pankiv, Oleg Shvets, Inna Gogunska, Svitlana Reg
    Nutrients.2024; 16(2): 270.     CrossRef
  • Vitamin D Supplementation: A Review of the Evidence Arguing for a Daily Dose of 2000 International Units (50 µg) of Vitamin D for Adults in the General Population
    Pawel Pludowski, William B. Grant, Spyridon N. Karras, Armin Zittermann, Stefan Pilz
    Nutrients.2024; 16(3): 391.     CrossRef
  • Clinical Characteristics and Outcomes of Limb Fractures in Saudi Children
    Lamia Aldhbiban, Fai Alhoshan, Raghad Alomari, Shahad A Almatrafi, Yousef Alanazi, Samir Alsayegh, Haifa Y Alfaraidi, Ayman H Jawadi, Fahad N Aljuraibah
    Cureus.2024;[Epub]     CrossRef
  • The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches
    Nikhil Gupta, Navjot Kanwar, Anchal Arora, Kavin Khatri, Abhinav Kanwal
    Clinical Rheumatology.2024; 43(5): 1421.     CrossRef
  • The multi-faceted nature of age-associated osteoporosis
    A.E. Smit, O.C. Meijer, E.M. Winter
    Bone Reports.2024; 20: 101750.     CrossRef
  • Vitamin D Deficiency in Patients With Low-Energy Hip Fractures in Accordance With the Mediterranean Paradox
    Christos Konstantinidis, Ourania Psoma, Christos Kotsias, Vasileios Panagiotopoulos , Sotiris Plakoutsis, Dimitrios Tsiampas, Dimitrios Vardakas, Dimitrios Giotis
    Cureus.2024;[Epub]     CrossRef
  • Effect of vitamin D, calcium, or combined supplementation on fall prevention: a systematic review and updated network meta-analysis
    Long Tan, Ruiqian He, Xiaoxue Zheng
    BMC Geriatrics.2024;[Epub]     CrossRef
  • Analysis of medication treatment for women with osteoporosis: A real-world retrospective study from Chinese tertiary grade A hospital
    Xiaolei Liu, Zhenling Zhu, Xianli Wang
    Bone Reports.2024; 21: 101778.     CrossRef
  • New insights into dairy management and the prevention and treatment of osteoporosis: The shift from single nutrient to dairy matrix effects—A review
    Kaili Wang, Xu Zhao, Sijia Yang, Xiaoxi Qi, Aili Li, Wei Yu
    Comprehensive Reviews in Food Science and Food Safety.2024;[Epub]     CrossRef
  • The Importance of Vitamin K and the Combination of Vitamins K and D for Calcium Metabolism and Bone Health: A Review
    Jan O. Aaseth, Trine Elisabeth Finnes, Merete Askim, Jan Alexander
    Nutrients.2024; 16(15): 2420.     CrossRef
  • The role of anti-osteoporosis drugs in fall risk
    Gianpaolo Voltan, Nicola Veronese
    International Journal of Bone Fragility.2024; 4(1): 2.     CrossRef
  • Pharmacologic or genetic interference with atrogene signaling protects against glucocorticoid-induced musculoskeletal and cardiac disease
    Amy Y. Sato, Meloney Cregor, Kevin McAndrews, Charles A. Schurman, Eric Schaible, Jennifer Shutter, Punit Vyas, Bhawana Adhikari, Monte S. Willis, Marjan Boerma, Tamara Alliston, Teresita Bellido
    JCI Insight.2024;[Epub]     CrossRef
  • Vitamin D levels and bone mineral density: a prospective cross-sectional analysis of young orthopedic trauma patients at a rural United States trauma center
    Michael Booth, Kenneth Sabacinski, Colleen Watkins, Erin Butcho, Emilie Kramer, Lukas Meadows, Michelle A. Bramer
    Journal of Trauma and Injury.2024; 37(4): 276.     CrossRef
  • Preventing Osteoporosis Caused by Vitamin D Deficiency: Nursing Interventions, Nutritional Approaches, and Laboratory Monitoring
    Fatima Naif Mabrok Aljohani, Nehad Ali Mohammed Malhawi, Hana Aldafi Haywan Alanazi, Munırah Sumaydan Hamoud Aljohan, Reham Saud Abdulaziz Alahmad, Abdulazız Mohammed Abdullah Alshehrı, Eman Mohammed Abdullah Al Hazim, Hamad Alı Mohammed Alqaed,
    International Journal of Computational and Experimental Science and Engineering.2024;[Epub]     CrossRef
  • Association of vitamin and/or nutritional supplements with fall among patients with diabetes: A prospective study based on ACCORD and UK Biobank
    Lingfang He, Tianqi Ma, Guogang Zhang, Xunjie Cheng, Yongping Bai
    Frontiers in Nutrition.2023;[Epub]     CrossRef
  • Vitamin D and Calcium in Osteoporosis, and the Role of Bone Turnover Markers: A Narrative Review of Recent Data from RCTs
    Gavriela Voulgaridou, Sousana K. Papadopoulou, Paraskevi Detopoulou, Despoina Tsoumana, Constantinos Giaginis, Foivi S. Kondyli, Evgenia Lymperaki, Agathi Pritsa
    Diseases.2023; 11(1): 29.     CrossRef
  • Recent advances in the identification of related factors and preventive strategies of hip fracture
    Yaohui Yu, Yudan Wang, Xiaoli Hou, Faming Tian
    Frontiers in Public Health.2023;[Epub]     CrossRef
  • Can Nutrition Contribute to a Reduction in Sarcopenia, Frailty, and Comorbidities in a Super-Aged Society?
    Sadao Yoshida, Ryo Shiraishi, Yuki Nakayama, Yasuko Taira
    Nutrients.2023; 15(13): 2991.     CrossRef
  • Safety Profile of Vitamin D in Italy: An Analysis of Spontaneous Reports of Adverse Reactions Related to Drugs and Food Supplements
    Valentina Maggini, Giada Crescioli, Ilaria Ippoliti, Eugenia Gallo, Francesca Menniti-Ippolito, Adelaide Chiaravalloti, Vittorio Mascherini, Roberto Da Cas, Simona Potenza, Giulia Gritti, Maria Galiulo, Laura Sottosanti, Alfredo Vannacci, Niccolò Lombardi
    Journal of Clinical Medicine.2023; 12(14): 4726.     CrossRef
  • Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly
    Sabrina Chiloiro, Stefano Frara, Irene Gagliardi, Antonio Bianchi, Antonella Giampietro, Margherita Medici, Agnese Allora, Luigi di Filippo, Maria Rosaria Ambrosio, Alfredo Pontecorvi, Maria Chiara Zatelli, Laura De Marinis, Andrea Giustina
    The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): e58.     CrossRef
  • Proceedings of the 2023 Santa Fe Bone Symposium: Progress and Controversies in the Management of Patients with Skeletal Diseases
    E. Michael Lewiecki, Teresita Bellido, John P. Bilezikian, Jacques P. Brown, Azeez Farooki, Christopher S. Kovacs, Brendan Lee, William D. Leslie, Michael R. McClung, Mark L. Prasarn, Deborah E. Sellmeyer
    Journal of Clinical Densitometry.2023; 26(4): 101432.     CrossRef
  • Diagnosis, prevention and treatment of vitamin D deficiency in adults: Ukrainian experts consensus statement
    N.V. Grygorieva, M.D. Tronko, V.M. Kovalenko, S.V. Komisarenko, T.F. Tatarchuk, N.V. Dedukh, M.M. Veliky, S.S. Strafun, Y.I. Komisarenko, A.V. Kalashnikov, V.L. Orlenko, V.I. Pankiv, O.V. Shvets, I.V. Gogunska, S.I. Regeda
    PAIN, JOINTS, SPINE.2023; 13(2): 60.     CrossRef
  • Serum 25-Hydroxyvitamin D Level Is Negatively Associated with Fatigue in Elderly Maintenance Hemodialysis Patients
    Menglin Pang, Lin Chen, Na Jiang, Mengmeng Jiang, Baofeng Wang, Lili Wang, Xiao-yan Jia
    Kidney and Blood Pressure Research.2023; 48(1): 231.     CrossRef
  • Vitamin D for Clinical Diseases in Women: An Indispensable Factor in Medicine and Dentistry
    Dario Calafiore, Leonzio Fortunato, Mario Migliario
    Journal of Clinical Medicine.2022; 11(11): 3104.     CrossRef
  • Malnutrition in Older Adults—Effect on Falls and Fractures: A Narrative Review
    Malgorzata Kupisz-Urbanska, Ewa Marcinowska-Suchowierska
    Nutrients.2022; 14(15): 3123.     CrossRef
  • Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group
    Thierry Chevalley, Maria Luisa Brandi, Kevin D. Cashman, Etienne Cavalier, Nicholas C. Harvey, Stefania Maggi, Cyrus Cooper, Nasser Al-Daghri, Oliver Bock, Olivier Bruyère, Mario Miguel Rosa, Bernard Cortet, Alfonso J. Cruz-Jentoft, Antonio Cherubini, Bes
    Aging Clinical and Experimental Research.2022; 34(11): 2603.     CrossRef
  • The Relationship of Osteoporosis with Menopause: Review of Article
    Hadeel Anwar Alsarraje, *Liqaa Khalel Alhyali
    International Journal of Research in Medical Sciences and Technology.2022; 14(01): 127.     CrossRef
Close layer
Review Article
Mineral, Bone & Muscle
Applications of Machine Learning in Bone and Mineral Research
Sung Hye Kong, Chan Soo Shin
Endocrinol Metab. 2021;36(5):928-937.   Published online October 21, 2021
DOI: https://doi.org/10.3803/EnM.2021.1111
  • 10,350 View
  • 237 Download
  • 23 Web of Science
  • 22 Crossref
AbstractAbstract PDFPubReader   ePub   
In this unprecedented era of the overwhelming volume of medical data, machine learning can be a promising tool that may shed light on an individualized approach and a better understanding of the disease in the field of osteoporosis research, similar to that in other research fields. This review aimed to provide an overview of the latest studies using machine learning to address issues, mainly focusing on osteoporosis and fractures. Machine learning models for diagnosing and classifying osteoporosis and detecting fractures from images have shown promising performance. Fracture risk prediction is another promising field of research, and studies are being conducted using various data sources. However, these approaches may be biased due to the nature of the techniques or the quality of the data. Therefore, more studies based on the proposed guidelines are needed to improve the technical feasibility and generalizability of artificial intelligence algorithms.

Citations

Citations to this article as recorded by  
  • Intelligent porosity control in hydroxyapatite using fuzzy logic and electronic doping tuning for advanced biofunctional materials
    P. Veeraragavan, M. Sridevi, P. Madhavasarma
    Materials Chemistry and Physics.2026; 350: 131885.     CrossRef
  • Harnessing Biophysical Approaches in Unlocking Bone Health: A Toolkit for Clinicians and Researchers
    Simran Preet Kaur, Anurag Singh, Swati Rajput, Asha Bhardwaj, Rupesh K. Srivastava
    ACS Biomaterials Science & Engineering.2026; 12(1): 90.     CrossRef
  • Artificial intelligence in bone biology: Transforming basic research into advanced therapeutics
    Cheng Li, Zheng Zhong, Ning Zhang, Shuai Yuan, Ruifeng Fang, Fengjun Ge, Weibin Yan, Di Zhang, Denghui Xie
    The Innovation Life.2026; 4(1): 100186.     CrossRef
  • Artificial Intelligence in Rheumatology: From Algorithms to Clinical Impact in Osteoporosis and Chronic Inflammatory Rheumatic Diseases
    Marie Doussiere, Ahlem Aboud, Gilles Dequen, Vincent Goëb
    Journal of Clinical Medicine.2026; 15(2): 491.     CrossRef
  • Artificial intelligence for predicting the risk of bone fragility fractures in osteoporosis
    Fabio Massimo Ulivieri, Carmelo Messina, Francesco Maria Vitale, Luca Rinaudo, Enzo Grossi
    European Radiology Experimental.2025;[Epub]     CrossRef
  • Incorporating Artificial Intelligence into Fracture Risk Assessment: Using Clinical Imaging to Predict the Unpredictable
    Sung Hye Kong
    Endocrinology and Metabolism.2025; 40(4): 499.     CrossRef
  • Prediction of biomechanical properties of ex vivo human femoral cortical bone using Raman spectroscopy and machine learning algorithms
    Mustafa UNAL, Ramazan UNLU, Sasidhar UPPUGANTI, Jeffry S. NYMAN
    Bone Reports.2025; 26: 101870.     CrossRef
  • Prophylactic fixation in elderly fractures: Preventive breakthrough or unnecessary intervention?
    Mohamed Sameer, Sathish Muthu, Srujun Vadranapu
    World Journal of Orthopedics.2025;[Epub]     CrossRef
  • Artificial Intelligence and Machine Learning in the Diagnosis and Management of Osteoporosis: A Comprehensive Review
    Alessandro Conforti, Marco Ruggiero, Linda Lucchetti, Valerio Cipolloni, Francesco Demostene Galati, Martina Gentile, Alberto Lo Gullo
    Medicina.2025; 62(1): 27.     CrossRef
  • Predicting postoperative outcomes in lumbar spinal fusion: development of a machine learning model
    Lukas Schönnagel, Thomas Caffard, Tu-Lan Vu-Han, Jiaqi Zhu, Isaac Nathoo, Kyle Finos, Gaston Camino-Willhuber, Soji Tani, Ali. E. Guven, Henryk Haffer, Maximilian Muellner, Artine Arzani, Erika Chiapparelli, Krizia Amoroso, Jennifer Shue, Roland Duculan,
    The Spine Journal.2024; 24(2): 239.     CrossRef
  • A CT-based Deep Learning Model for Predicting Subsequent Fracture Risk in Patients with Hip Fracture
    Yisak Kim, Young-Gon Kim, Jung-Wee Park, Byung Woo Kim, Youmin Shin, Sung Hye Kong, Jung Hee Kim, Young-Kyun Lee, Sang Wan Kim, Chan Soo Shin
    Radiology.2024;[Epub]     CrossRef
  • Applying machine learning classification techniques for disease diagnosis from medical imaging data using Transformer based Attention Guided CNN (TAGCNN)
    Saleh Alyahyan
    Multimedia Tools and Applications.2024; 83(29): 72861.     CrossRef
  • Machine Learning in Assessing Canine Bone Fracture Risk: A Retrospective and Predictive Approach
    Ernest Kostenko, Jakov Šengaut, Algirdas Maknickas
    Applied Sciences.2024; 14(11): 4867.     CrossRef
  • A Computed Tomography–Based Fracture Prediction Model With Images of Vertebral Bones and Muscles by Employing Deep Learning: Development and Validation Study
    Sung Hye Kong, Wonwoo Cho, Sung Bae Park, Jaegul Choo, Jung Hee Kim, Sang Wan Kim, Chan Soo Shin
    Journal of Medical Internet Research.2024; 26: e48535.     CrossRef
  • Sensing the future: A review on emerging technologies for assessing and monitoring bone health
    Amruta Naik, Anup A. Kale, Jyutika M. Rajwade
    Biomaterials Advances.2024; 165: 214008.     CrossRef
  • Associations between longitudinal fluoride intakes from birth to age 23 and multi‐row detector computed tomography bone densitometry outcomes at age 23
    Gurjot Kaur Bhatia, Steven M. Levy, John J. Warren, Oscar A. Rysavy, Punam K. Saha, Xiaoliu Zhang, Erliang Zeng
    Journal of Public Health Dentistry.2024; 84(4): 428.     CrossRef
  • Artificial Intelligence Applications for Imaging Metabolic Bone Diseases
    Amanda Isaac, Asli Irmak Akdogan, Danoob Dalili, Nuran Saber, David Drobny, Giuseppe Guglielmi, Marc Modat, Alberto Bazzocchi
    Seminars in Musculoskeletal Radiology.2024; 28(05): 610.     CrossRef
  • From Genomics to Metabolomics: Molecular Insights into Osteoporosis for Enhanced Diagnostic and Therapeutic Approaches
    Qingmei Li, Jihan Wang, Congzhe Zhao
    Biomedicines.2024; 12(10): 2389.     CrossRef
  • Development and validation of common data model-based fracture prediction model using machine learning algorithm
    Sung Hye Kong, Sihyeon Kim, Yisak Kim, Jung Hee Kim, Kwangsoo Kim, Chan Soo Shin
    Osteoporosis International.2023; 34(8): 1437.     CrossRef
  • Machine learning algorithms for predicting the risk of fracture in patients with diabetes in China
    Sijia Chu, Aijun Jiang, Lyuzhou Chen, Xi Zhang, Xiurong Shen, Wan Zhou, Shandong Ye, Chao Chen, Shilu Zhang, Li Zhang, Yang Chen, Ya Miao, Wei Wang
    Heliyon.2023; 9(7): e18186.     CrossRef
  • Leveraging Artificial Intelligence and Machine Learning in Regenerative Orthopedics: A Paradigm Shift in Patient Care
    Madhan Jeyaraman, Harish V K Ratna, Naveen Jeyaraman, Aakaash Venkatesan, Swaminathan Ramasubramanian , Sankalp Yadav
    Cureus.2023;[Epub]     CrossRef
  • Quality use of artificial intelligence in medical imaging: What do radiologists need to know?
    Stacy K Goergen, Helen ML Frazer, Sandeep Reddy
    Journal of Medical Imaging and Radiation Oncology.2022; 66(2): 225.     CrossRef
Close layer
Original Articles
Clinical Study
Radioactive Parathyroid Adenomas on Sestamibi Scans: Low Parathyroid Hormone Secretory Potential and Large Volume
Sung Hye Kong, Jung Hee Kim, Sang Wan Kim, Chan Soo Shin
Endocrinol Metab. 2021;36(2):351-358.   Published online April 6, 2021
DOI: https://doi.org/10.3803/EnM.2020.823
  • 6,880 View
  • 165 Download
  • 4 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
We investigated the clinical characteristics of parathyroid adenomas according to radioactivity on 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) single-photon emission computed tomography/computed tomography (SPECT/CT) in primary hyperparathyroidism (PHPT) patients.
Methods
The study included 217 patients diagnosed with PHPT from 2000 to 2019 at Seoul National University Hospital who underwent 99mTc-MIBI SPECT/CT scans. On SPECT/CT, the radioactivity of parathyroid adenomas was measured as the ratio of the mean radioactivity count of the parathyroid adenoma to that of the contralateral thyroid.
Results
Tumors were localized by MIBI scans in 190 patients (MIBI [+] group) and by ultrasound or parathyroid four-dimensional CT in 27 patients (MIBI [–] group). The mean age was 55 years, and mean body mass index was 23.4 kg/m2. Patients in the MIBI (+) group had higher parathyroid hormone (iPTH) and lower 25-hydroxy vitamin D levels than those in the MIBI (–) group (168.0 pg/mL [interquartile range, IQR, 111.0 to 250.7] vs. 134.7 pg/mL [IQR, 98.2 to 191.2], P=0.049; 15.4 ng/mL [IQR, 11.1 to 20.8] vs. 21.2 ng/mL [IQR, 13.9 to 24.8], P=0.012, respectively). Patients in the MIBI (+) group had larger tumor volumes, but lower iPTH/volume ratios than those in the MIBI (–) group (1,216.66 [IQR, 513.40 to 2,663.02], 499.82 mm3 [IQR, 167.77 to 1,229.80], P=0.002; 0.18 [IQR, 0.08 to 0.46], 0.40 pg/mL/mm3 [IQR, 0.16 to 1.29], P=0.016, respectively). Adenoma radioactivity was positively correlated with calcium, iPTH, and volume (r=0.180, P=0.020; r=0.208, P=0.006; r=0.288, P<0.001, respectively), but not with iPTH/volume.
Conclusion
Parathyroid adenomas with positive MIBI scans had larger volumes and higher iPTH than adenomas with negative scans, but lower iPTH per unit volume.

Citations

Citations to this article as recorded by  
  • Study on Uptake Ratio of 99mTc-MIBI Parathyroid Scan
    Jung-Soo Kim, Jin-Eui Kim
    Journal of Radiological Science and Technology.2025; 48(5): 513.     CrossRef
  • Protein Signatures of Parathyroid Adenoma according to Tumor Volume and Functionality
    Sung Hye Kong, Jeong Mo Bae, Jung Hee Kim, Sang Wan Kim, Dohyun Han, Chan Soo Shin
    Endocrinology and Metabolism.2024; 39(2): 375.     CrossRef
  • Incidentally detected follicular thyroid carcinoma mimicking parathyroid adenoma on Tc-99m MIBI scan: A case report
    Yeon-Hee Han, Hwan-Jeong Jeong, Sun Young Lee, Seok Tae Lim
    Medicine.2024; 103(18): e38107.     CrossRef
  • Atypical parathyroid tumor: clinical and parathyroid hormone response to surgical treatment
    Antonio Giulio Napolitano, Massimo Monacelli, Valeria Liparulo, Eleonora Coviello, Domenico Pourmolkara, Stefano Avenia, Andrea Polistena
    Annals of Surgical Treatment and Research.2023; 105(2): 76.     CrossRef
  • The Relationship between Planar and SPECT/CT Parameters and Functional Markers in Primary Hyperparathyroidism
    Guler Silov, Serpil Erdogan Ozbodur
    Diagnostics.2023; 13(20): 3182.     CrossRef
Close layer
Clinical Study
Identification of Novel Genetic Variants Related to Trabecular Bone Score in Community-Dwelling Older Adults
Sung Hye Kong, Ji Won Yoon, Jung Hee Kim, JooYong Park, Jiyeob Choi, Ji Hyun Lee, A Ram Hong, Nam H. Cho, Chan Soo Shin
Endocrinol Metab. 2020;35(4):801-810.   Published online November 24, 2020
DOI: https://doi.org/10.3803/EnM.2020.735
  • 7,685 View
  • 122 Download
  • 4 Web of Science
  • 4 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
As the genetic variants of trabecular bone microarchitecture are not well-understood, we performed a genome-wide association study to identify genetic determinants of bone microarchitecture analyzed by trabecular bone score (TBS).
Methods
TBS-associated genes were discovered in the Ansung cohort (discovery cohort), a community-based rural cohort in Korea, and then validated in the Gene-Environment Interaction and Phenotype (GENIE) cohort (validation cohort), consisting of subjects who underwent health check-up programs. In the discovery cohort, 2,451 participants were investigated for 1.42 million genotyped and imputed markers.
Results
In the validation cohort, identified as significant variants were evaluated in 2,733 participants. An intronic variant in iroquois homeobox 3 (IRX3), rs1815994, was significantly associated with TBS in men (P=3.74E-05 in the discovery cohort, P=0.027 in the validation cohort). Another intronic variant in mitogen-activated protein kinase kinase 5 (MAP2K5), rs11630730, was significantly associated with TBS in women (P=3.05E-09 in the discovery cohort, P=0.041 in the validation cohort). Men with the rs1815994 variant and women with the rs11630730 variant had lower TBS and lumbar spine bone mineral density. The detrimental effects of the rs1815994 variant in men and rs11630730 variant in women were also identified in association analysis (β=–0.0281, β=–0.0465, respectively).
Conclusion
In this study, the rs1815994 near IRX3 in men and rs11630730 near MAP2K5 in women were associated with deterioration of the bone microarchitecture. It is the first study to determine the association of genetic variants with TBS. Further studies are needed to confirm our findings and identify additional variants contributing to the trabecular bone microarchitecture.

Citations

Citations to this article as recorded by  
  • A novel genetic mouse model of osteoporosis with double heterozygosity of Irx3 and Irx5 characterizes sex-dependent phenotypes in bone homeostasis
    Xinyu Chen, Zhengchao Dou, Joe Eun Son, Meng Duan, Fei Yang, Shankuan Zhu, Chi-Chung Hui
    Bone.2025; 190: 117282.     CrossRef
  • GRAMMAR-Lambda Delivers Efficient Understanding of the Genetic Basis for Head Size in Catfish
    Yunfeng Zhao, Jin Gao, Hong Feng, Li Jiang
    Biology.2025; 14(1): 63.     CrossRef
  • The 14-year cumulative genetic high blood pressure and risk of type 2 diabetes in Korean: observational and Mendelian randomization evidence
    Jooeun Jeon, Keum Ji Jung, Heejin Kimm, Ji-young Lee, Chung-Mo Nam, Sun Ha Jee
    Hypertension Research.2025; 48(4): 1274.     CrossRef
  • Neural EGFL like 1 as a novel gene for Trabecular Bone Score in older adults: The Bushehr Elderly Health (BEH) program
    Mohammad Bidkhori, Mahdi Akbarzadeh, Noushin Fahimfar, Mina Jahangiri, Sahar Seddiq, Bagher Larijani, Iraj Nabipour, Mahsa Mohammad Amoli, Nekoo Panahi, Abbas Dehghan, Kourosh Holakouie-Naieni, Afshin Ostovar, Dengshun Miao
    PLOS ONE.2024; 19(9): e0309401.     CrossRef
Close layer
Clinical Study
Subclinical Hypothyroidism Affects the Long-Term Outcomes of Patients Who Undergo Coronary Artery Bypass Grafting Surgery but Not Heart Valve Surgery
Hana Kim, Sung Hye Kong, Jae Hoon Moon, Sang Yoon Kim, Kay-Hyun Park, Jun Sung Kim, Joong Haeng Choh, Young Joo Park, Cheong Lim
Endocrinol Metab. 2020;35(2):308-318.   Published online June 24, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.2.308
  • 10,100 View
  • 174 Download
  • 12 Web of Science
  • 12 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
The aim of this study was to determine the associations between subclinical hypothyroidism (SCH) and long-term cardiovascular outcomes after coronary artery bypass grafting (CABG) or heart valve surgery (HVS).
Methods
We retrospectively reviewed and compared all-cause mortality, cardiovascular mortality, and cardiovascular events in 461 patients who underwent CABG and 104 patients who underwent HVS.
Results
During a mean±standard deviation follow-up duration of 7.6±3.8 years, there were 187 all-cause deaths, 97 cardiovascular deaths, 127 major adverse cardiovascular events (MACE), 11 myocardial infarctions, one unstable angina, 70 strokes, 30 hospitalizations due to heart failure, 101 atrial fibrillation, and 33 coronary revascularizations. The incidence of all-cause mortality after CABG was significantly higher in patients with SCH (n=36, 55.4%) than in euthyroid patients (n=120, 30.3%), with a hazard ratio of 1.70 (95% confidence interval, 1.10 to 2.63; P=0.018) after adjustment for age, sex, current smoking status, body mass index, underlying diseases, left ventricular dysfunction, and emergency operation. Interestingly, low total triiodothyronine (T3) levels in euthyroid patients who underwent CABG were significantly associated with increased risks of all-cause mortality, cardiovascular mortality, and MACE, but those associations were not observed in HVS patients. Both free thyroxine and thyroid-stimulating hormone levels in euthyroid patients were not related with any cardiovascular outcomes in either the CABG or HVS group.
Conclusion
SCH or low total T3 might be associated with a poor prognosis after CABG, but not after HVS, implying that preoperative thyroid hormonal status may be important in ischemic heart disease patients.

Citations

Citations to this article as recorded by  
  • Subclinical Hypothyroidism as a Risk for Coronary Artery Bypass Grafting
    Ricardo Mendes Martins, Felipe José M. Pittella, Beatriz C. de Oliveira, Bernardo G. S. Lima, Caio C. Ferreira, Aline D. Pereira, Wolney A. Martins, Rubens A. C. Filho, Giovanna A. B. Lima, Muhammad Riaz
    Cardiovascular Therapeutics.2026;[Epub]     CrossRef
  • The impact of thyroid function on surgical prognosis in patients undergoing cardiac and major vascular surgeries
    Qi Sun, Wei Wang, Xiaoming Mao, Hao Liu
    Journal of Cardiothoracic Surgery.2025;[Epub]     CrossRef
  • Subclinical hypothyroidism and clinical outcomes after cardiac surgery: A systematic review and meta-analysis
    Michele Dell’Aquila, Camilla S. Rossi, Tulio Caldonazo, Gianmarco Cancelli, Lamia Harik, Giovanni J. Soletti, Kevin R. An, Jordan Leith, Hristo Kirov, Mudathir Ibrahim, Michelle Demetres, Arnaldo Dimagli, Mohamed Rahouma, Mario Gaudino
    JTCVS Open.2024; 18: 64.     CrossRef
  • Impact of subclinical hypothyroidism on outcomes after coronary artery bypass grafting: a systematic review and meta-analysis
    Muhammad O. LARIK, Abdul R. SHAHID, Moeez I. SHIRAZ, Maryam UROOJ
    The Journal of Cardiovascular Surgery.2024;[Epub]     CrossRef
  • The Association Between Hypothyroidism Treatment and Mortality in Patients Hospitalized in Surgical Wards
    Hiba Masri-Iraqi, Yaron Rudman, Carmel Friedrich Dubinchik, Idit Dotan, Talia Diker-Cohen, Liat Sasson, Tzipora Shochat, Ilan Shimon, Eyal Robenshtok, Amit Akirov
    Endocrine Research.2023; 48(2-3): 68.     CrossRef
  • Mid-term outcomes of patients with subclinical hypothyroidism after coronary bypass surgery
    Dong Zhao, Wei Zhao, Chuangshi Wang, Fei Xu, Wei Zhao, Xieraili Tiemuerniyazi, Hao Ma, Wei Feng
    Interdisciplinary CardioVascular and Thoracic Surgery.2023;[Epub]     CrossRef
  • Thyroid Pathology in High-Risk Cardiac Surgery Patients with Coronary Artery Disease
    Olena K. Gogayeva, Anatoliy V. Rudenko, Vasyl V. Lazoryshynets, Serhii A. Rudenko, Tetiana A. Andrushchenko
    Ukrainian Journal of Cardiovascular Surgery.2022; 30(1 (46)): 9.     CrossRef
  • High-TSH Subclinical Hypothyroidism Is Associated With Postoperative Mortality in Acute Type A Aortic Dissection
    Shi-Pan Wang, Yuan Xue, Hai-Yang Li, Wen-Jian Jiang, Hong-Jia Zhang
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Triiodothyronine improves contractile recovery of human atrial trabeculae after hypoxia/reoxygenation
    Petra Kleinbongard, Philipp Kuthan, Chantal Eickelmann, Philipp Jakobs, Joachim Altschmied, Judith Haendeler, Arjang Ruhparwar, Matthias Thielmann, Gerd Heusch
    International Journal of Cardiology.2022; 363: 159.     CrossRef
  • Hypothyroidism Is Correlated with Ventilator Complications and Longer Hospital Days after Coronary Artery Bypass Grafting Surgery in a Relatively Young Population: A Nationwide, Population-Based Study
    Jiun-Yu Lin, Pei-Chi Kao, Yi-Ting Tsai, Chi-Hsiang Chung, Wu-Chien Chien, Chih-Yuan Lin, Chieh-Hua Lu, Chien-Sung Tsai
    Journal of Clinical Medicine.2022; 11(13): 3881.     CrossRef
  • Minor perturbations of thyroid homeostasis and major cardiovascular endpoints—Physiological mechanisms and clinical evidence
    Patrick Müller, Melvin Khee-Shing Leow, Johannes W. Dietrich
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Subclinical Hypothyroidism: Prevalence, Health Impact, and Treatment Landscape
    Won Sang Yoo, Hyun Kyung Chung
    Endocrinology and Metabolism.2021; 36(3): 500.     CrossRef
Close layer
Clinical Study
Protein Expression of Cyclin B1, Transferrin Receptor, and Fibronectin Is Correlated with the Prognosis of Adrenal Cortical Carcinoma
Sun Joon Moon, Jung Hee Kim, Sung Hye Kong, Chan Soo Shin
Endocrinol Metab. 2020;35(1):132-141.   Published online March 19, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.1.132
  • 13,551 View
  • 103 Download
  • 13 Web of Science
  • 13 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Adrenal cortical carcinoma (ACC) is a rare cancer with a variable prognosis. Several prognostic factors of ACC have been previously reported, but a proteomic analysis has not yet been performed. This study aimed to investigate prognostic biomarkers for ACC using a proteomic approach.

Methods

We used reverse-phase protein array data from The Cancer Proteome Atlas, and identified differentially expressed proteins in metastatic ACCs. Multivariate Cox regression analysis adjusted by age and staging was used for survival analysis, and the C-index and category-free net reclassification improvement (cfNRI) were utilized to evaluate additive prognostic value.

Results

In 46 patients with ACC, cyclin B1, transferrin receptor (TfR1), and fibronectin were significantly overexpressed in patients with distant metastasis. In multivariate models, high expression of cyclin B1 and TfR1 was significantly associated with mortality (hazard ratio [HR], 6.13; 95% confidence interval [CI], 1.02 to 36.7; and HR, 6.59; 95% CI, 1.14 to 38.2; respectively), whereas high fibronectin expression was not (HR, 3.92; 95% CI, 0.75 to 20.4). Combinations of high cyclin B1/high TfR1, high cyclin B1/high fibronectin, and high TfR1/high fibronectin were strongly associated with mortality ([HR, 13.72; 95% CI, 1.89 to 99.66], [HR, 9.22; 95% CI, 1.34 to 63.55], and [HR, 18.59; 95% CI, 2.54 to 135.88], respectively). In reclassification analyses, cyclin B1, TfR1, fibronectin, and combinations thereof improved the prognostic performance (C-index, 0.78 to 0.82–0.86; cfNRI, all P values <0.05).

Conclusion

In ACC patients, the overexpression of cyclin B1, TfR1, and fibronectin and combinations thereof were associated with poor prognosis.

Citations

Citations to this article as recorded by  
  • Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy
    Naoki Ikenaga, Tsuyoshi Takahashi, Koji Tanaka, Satoshi Serada, Minoru Fujimoto, Kota Momose, Kotaro Yamashita, Tomoki Makino, Takuro Saito, Kazuyoshi Yamamoto, Yukinori Kurokawa, Kiyokazu Nakajima, Tomomi Fujii, Eiichi Morii, Tetsuji Naka, Hidetoshi Eguc
    Cancer Science.2026; 117(2): 393.     CrossRef
  • A proimmunotoxin nanodrug targeting AIDS-associated non-Hodgkin lymphoma
    Shilin Chen, Tong Qi, Hongxu Peng, Eugene Kimura, Xiang Zhang, Emiko Kranz, Zheng Cao, Zi Wang, Wenting Chen, Leonardo R. Ancheta, Douglas A. Lappi, Pei-Yu Chiou, Yunfeng Lu, Tracy R. Daniels-Wells, Manuel L. Penichet, Jing Wen
    Journal of Controlled Release.2026; 392: 114661.     CrossRef
  • Identification of Key Genes and Related Drugs of Adrenocortical Carcinoma by Integrated Bioinformatics Analysis
    Jian-bin Wei, Xiao-chun Zeng, Kui-rong Ji, Ling-yi Zhang, Xiao-min Chen
    Hormone and Metabolic Research.2024; 56(08): 593.     CrossRef
  • Synthesis and Evaluation of [64Cu]Cu-NOTA-HFn for PET Imaging of Transferrin Receptor 1 Expression in Nasopharyngeal Carcinoma
    Yanfang Shen, Renwei Zhou, Lei Bi, Guolong Huang, Min Yang, Zhijun Li, Jijin Yao, Jianzhong Xian, Yifan Qiu, Peizhen Ye, Yongshan Liu, Yuyi Hou, Hongjun Jin, Ying Wang
    ACS Omega.2024;[Epub]     CrossRef
  • An affordable label-free ultrasensitive immunosensor based on gold nanoparticles deposited on glassy carbon electrode for the transferrin receptor detection
    Abrar Ahmad, Gulam Rabbani, Mazin A. Zamzami, Salman Hosawi, Othman A. Baothman, Hisham Altayeb, Muhammad Shahid Nadeem Akhtar, Varish Ahmad, Mohsin Vahid Khan, Mohammad Ehtisham Khan, Se Hyun Kim
    International Journal of Biological Macromolecules.2024; 273: 133083.     CrossRef
  • USP39-mediated deubiquitination of Cyclin B1 promotes tumor cell proliferation and glioma progression
    Yue Xiao, Xinyi Chen, Weiwei Hu, Wenjing Ma, Qianqian Di, Haimei Tang, Xibao Zhao, Guodong Huang, Weilin Chen
    Translational Oncology.2023; 34: 101713.     CrossRef
  • Identification of key genes and pathways in adrenocortical carcinoma: evidence from bioinformatic analysis
    Mengsha Yin, Yao Wang, Xinhua Ren, Mingyue Han, Shanshan Li, Ruishuang Liang, Guixia Wang, Xiaokun Gang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Ferritin nanocage based delivery vehicles: From single-, co- to compartmentalized- encapsulation of bioactive or nutraceutical compounds
    Hai Chen, Xiaoyi Tan, Xueer Han, Liang Ma, Hongjie Dai, Yu Fu, Yuhao Zhang
    Biotechnology Advances.2022; 61: 108037.     CrossRef
  • Effect of Inactivation of Mst1 and Mst2 in the Mouse Adrenal Cortex
    Nour Abou Nader, Étienne Blais, Guillaume St-Jean, Derek Boerboom, Gustavo Zamberlam, Alexandre Boyer
    Journal of the Endocrine Society.2022;[Epub]     CrossRef
  • Cyclin B1 expression as an independent prognostic factor for lung adenocarcinoma and its potential pathways
    Yi Li, Yuanxiu Leng, Yudi Dong, Yongxiang Song, Qiaoyuan Wu, Ni Jiang, Hui Dong, Fang Chen, Qing Luo, Chen Cheng
    Oncology Letters.2022;[Epub]     CrossRef
  • Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents
    Pierre V. Candelaria, Lai Sum Leoh, Manuel L. Penichet, Tracy R. Daniels-Wells
    Frontiers in Immunology.2021;[Epub]     CrossRef
  • Mass Spectrometry-Based Proteomic Discovery of Prognostic Biomarkers in Adrenal Cortical Carcinoma
    Han Na Jang, Sun Joon Moon, Kyeong Cheon Jung, Sang Wan Kim, Hyeyoon Kim, Dohyun Han, Jung Hee Kim
    Cancers.2021; 13(15): 3890.     CrossRef
  • Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer
    Milad Ashrafizadeh, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, Vahideh Zarrin, Sharareh Hosseinzadeh Kashani, Saied Bokaie, Masoud Najafi, Shima Tavakol, Reza Mohammadinejad, Noushin Nabavi, Chia-Ling Hsieh, Atefeh Zarepour, Ehsan Nazarzadeh Zare, Ali Z
    Bioengineering.2020; 7(3): 91.     CrossRef
Close layer
Corrigendum
Miscellaneous
Corrigendum: Author's Name Correction. Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro)
Jae Hoon Moon, Ji-hoon Kim, Eun Kyung Lee, Kyu Eun Lee, Sung Hye Kong, Yeo Koon Kim, Woo-Jin Jeong, Chang Yoon Lee, Roh-Eul Yoo, Yul Hwangbo, Young Shin Song, Min Joo Kim, Sun Wook Cho, Su-jin Kim, Eun-Jae Chung, June Young Choi, Chang Hwan Ryu, You Jin Lee, Jeong Hun Hah, Yuh-Seog Jung, Junsun Ryu, Yunji Hwang, Sue K. Park, Ho Kyung Sung, Ka Hee Yi, Do Joon Park, Young Joo Park
Endocrinol Metab. 2018;33(3):427.   Published online August 14, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.3.427
  • 5,524 View
  • 51 Download
  • 2 Web of Science
  • 2 Crossref
PDFPubReader   ePub   

Citations

Citations to this article as recorded by  
  • Invasiveness and Metastatic Aggressiveness in Small Differentiated Thyroid Cancers: Demography of Small Papillary Thyroid Carcinomas in the Swedish Population
    Haytham Bayadsi, Martin Bergman, Malin Sund, Joakim Hennings
    World Journal of Surgery.2020; 44(2): 461.     CrossRef
  • Clinical and pathologic predictors of lymph node metastasis in papillary thyroid microcarcinomas
    Ling Zhao, Xiaoya Sun, Yukun Luo, Fulin Wang, Zhaohui Lyu
    Annals of Diagnostic Pathology.2020; 49: 151647.     CrossRef
Close layer
Original Articles
Thyroid
Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro)
Jae Hoon Moon, Ji-hoon Kim, Eun Kyung Lee, Kyu Eun Lee, Sung Hye Kong, Yeo Koon Kim, Woo-jin Jung, Chang Yoon Lee, Roh-Eul Yoo, Yul Hwangbo, Young Shin Song, Min Joo Kim, Sun Wook Cho, Su-jin Kim, Eun Jae Jung, June Young Choi, Chang Hwan Ryu, You Jin Lee, Jeong Hun Hah, Yuh-Seog Jung, Junsun Ryu, Yunji Hwang, Sue K. Park, Ho Kyung Sung, Ka Hee Yi, Do Joon Park, Young Joo Park
Endocrinol Metab. 2018;33(2):278-286.   Published online June 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.2.278
  • 8,898 View
  • 111 Download
  • 41 Web of Science
  • 40 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

The ongoing Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro) aims to observe the natural course of papillary thyroid microcarcinoma (PTMC), develop a protocol for active surveillance (AS), and compare the long-term prognosis, quality of life, and medical costs between the AS and immediate surgery groups.

Methods

This multicenter prospective cohort study of PTMC started in June 2016. The inclusion criteria were suspicious of malignancy or malignancy based on fine needle aspiration or core needle biopsy, age of ≥18 years, and a maximum diameter of ≤1 cm. If there was no major organ involvement, no lymph node/distant metastasis, and no variants with poor prognosis, the patients were explained of the pros and cons of immediate surgery and AS before selecting AS or immediate surgery. Follow-up visits (physical examination, ultrasonography, thyroid function, and questionnaires) are scheduled every 6 months during the first 2 years, and then every 1 year thereafter. Progression was defined as a maximum diameter increase of ≥3, ≥2 mm in two dimensions, suspected organ involvement, or lymph node/distant metastasis.

Results

Among 439 enrolled patients, 290 patients (66.1%) chose AS and 149 patients (33.9%) chose immediate surgery. The median follow-up was 6.7 months (range, 0.2 to 11.9). The immediate surgery group had a larger maximum tumor diameter, compared to the AS group (7.1±1.9 mm vs. 6.6±2.0 mm, respectively; P=0.014).

Conclusion

The results will be useful for developing an appropriate PTMC treatment policy based on its natural course and risk factors for progression.

Citations

Citations to this article as recorded by  
  • Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer: Protocol of a Multicenter Cluster-Randomized Trial (MAeSTro-SDM)
    Eun Kyung Lee, Min Joo Kim, Yul Hwangbo, Jae Hoon Moon, Sun Wook Cho, Young Jun Chai, June Young Choi, Yuh-Seog Jung, Kyu Eun Lee, Eun-Jae Chung, Kyungsik Kim, Su-jin Kim, Woochul Kim, Yoo Hyung Kim, Young Ki Lee, Jinsun Jang, Young Shin Song, Ka Hee Yi,
    Journal of Korean Medical Science.2026;[Epub]     CrossRef
  • A Personalized, Risk-Based Approach to Active Surveillance for Prostate Cancer with Takeaways from Broader Oncology Practices: A Mixed Methods Review
    Jeroen J. Lodder, Sebastiaan Remmers, Roderick C. N. van den Bergh, Arnoud W. Postema, Pim J. van Leeuwen, Monique J. Roobol
    Journal of Personalized Medicine.2025; 15(3): 84.     CrossRef
  • 2025 Korean Thyroid Association Clinical Management Guideline on Active Surveillance for Low-Risk Papillary Thyroid Carcinoma
    Eun Kyung Lee, Min Joo Kim, Seung Heon Kang, Bon Seok Koo, Kyungsik Kim, Mijin Kim, Bo Hyun Kim, Ji-hoon Kim, Shin Je Moon, Kyorim Back, Young Shin Song, Jong-hyuk Ahn, Hwa Young Ahn, Ho-Ryun Won, Won Sang Yoo, Min Kyoung Lee, Jeongmin Lee, Ji Ye Lee, Kyo
    International Journal of Thyroidology.2025; 18(1): 30.     CrossRef
  • 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
    Matthew D. Ringel, Julie Ann Sosa, Zubair Baloch, Lindsay Bischoff, Gary Bloom, Gregory A. Brent, Pamela L. Brock, Roger Chou, Robert R. Flavell, Whitney Goldner, Elizabeth G. Grubbs, Megan Haymart, Steven M. Larson, Angela M. Leung, Joseph Osborne, John
    Thyroid®.2025; 35(8): 841.     CrossRef
  • Ultrasound for Active Surveillance of Low-Risk Thyroid Carcinoma
    Sang Yull Kang, Hyeong Eun Jeong, Ha Rim Ahn, Hyun Jo Youn
    Journal of Surgical Ultrasound.2025; 12(2): 23.     CrossRef
  • MET-receptor targeted fluorescent imaging and spectroscopy to detect multifocal papillary thyroid cancer
    Madelon J. H. Metman, Pascal K. C. Jonker, Luc H. J. Sondorp, Bettien M. van Hemel, Mark S. Sywak, Anthony J. Gill, Liesbeth Jansen, Paul J. van Diest, Tessa M. van Ginhoven, Clemens W. G. M. Löwik, Anh H. Nguyen, Dominic J. Robinson, Gooitzen M. van Dam,
    European Journal of Nuclear Medicine and Molecular Imaging.2024; 51(8): 2384.     CrossRef
  • 2023 Update of the Korean Thyroid Association Guidelines for the Management of Thyroid Nodules
    Eun Kyung Lee, Young Joo Park
    Clinical Thyroidology®.2024; 36(4): 153.     CrossRef
  • Ultrasound Imaging in Active Surveillance of Small, Low-Risk Papillary Thyroid Cancer
    Sangeet Ghai, David P Goldstein, Anna M Sawka
    Korean Journal of Radiology.2024; 25(8): 749.     CrossRef
  • Standardized Ultrasound Evaluation for Active Surveillance of Low-Risk Thyroid Microcarcinoma in Adults: 2024 Korean Society of Thyroid Radiology Consensus Statement
    Ji Ye Lee, Min Kyoung Lee, Hyun Kyung Lim, Chang Yoon Lee, Jin Yong Sung, Jung Hyun Yoon, Soo Yeon Han, Jung Hee Shin, Ji-hoon Kim, So Lyung Jung, Sae Rom Chung, Jung Hwan Baek, Dong Gyu Na
    Korean Journal of Radiology.2024; 25(11): 942.     CrossRef
  • Standardized Ultrasound Evaluation for Active Surveillance of Low-Risk Thyroid Microcarcinoma in Adults: 2024 Korean Society of Thyroid Radiology Consensus Statement
    Ji Ye Lee, Min Kyoung Lee, Hyun Kyung Lim, Chang Yoon Lee, Jin Yong Sung, Jung Hyun Yoon, Soo Yeon Hahn, Jung Hee Shin, Ji-hoon Kim, So Lyung Jung, Sae Rom Chung, Jung Hwan Baek, Dong Gyu Na
    Journal of the Korean Society of Radiology.2024; 85(6): 1060.     CrossRef
  • Psychological adjustment to initial treatment for low‐risk thyroid cancer: Preliminary study
    Gabriella T. Seo, Mark L. Urken, Lauren E. Wein, Michael P. Saturno, Danielle Kapustin, Monica H. Xing, Lauren E. Yue, Eric M. Dowling, Tracey A. Revenson, Katherine J. Roberts, Robert Michael Tuttle
    Head & Neck.2023; 45(2): 439.     CrossRef
  • Response to Letter to the Editor on Surgical Outcomes in Patients With Low-Risk Papillary Thyroid Microcarcinoma From MAeSTro Study: Immediate Operation Versus Delayed Operation Following Active Surveillance: A Multicenter Prospective Cohort Study
    Hyeonuk Hwang, June Young Choi, Jae Hoon Moon, Eun Kyung Lee, Young Joo Park, Su-jin Kim, Yuh-Seog Jung
    Annals of Surgery Open.2023; 4(3): e311.     CrossRef
  • Lower Thyroid Cancer Mortality in Patients Detected by Screening: A Meta-Analysis
    Shinje Moon, Young Shin Song, Kyong Yeun Jung, Eun Kyung Lee, Young Joo Park
    Endocrinology and Metabolism.2023; 38(1): 93.     CrossRef
  • To Screen or Not to Screen?
    Do Joon Park
    Endocrinology and Metabolism.2023; 38(1): 69.     CrossRef
  • Surgical Outcomes in Patients With Low-risk Papillary Thyroid Microcarcinoma From MAeSTro Study
    Hyeonuk Hwang, June Young Choi, Hyeong Won Yu, Jae Hoon Moon, Ji-hoon Kim, Eun Kyung Lee, Yeo Koon Kim, Chang Yoon Lee, Sun Wook Cho, Eun-Jae Chung, Chang Hwan Ryu, Junsun Ryu, Ka Hee Yi, Do Joon Park, Kyu Eun Lee, Young Joo Park, Su-jin Kim, Yuh-Seog Jun
    Annals of Surgery.2023; 278(5): e1087.     CrossRef
  • US Predictors of Papillary Thyroid Microcarcinoma Progression at Active Surveillance
    Ji Ye Lee, Ji-hoon Kim, Yeo Koon Kim, Chang Yoon Lee, Eun Kyung Lee, Jae Hoon Moon, Hoon Sung Choi, Hwangbo Yul, Sun Wook Cho, Su-jin Kim, Kyu Eun Lee, Do Joon Park, Young Joo Park
    Radiology.2023;[Epub]     CrossRef
  • Active Surveillance of Thyroid Microcarcinomas: a Critical View
    Claudio R. Cernea, Leandro Luongo Matos, Cecília Eugênio, Giovanna Mattos Ferreira, Yasmin Sa Cerqueira, Ana Kober N. Leite, Felipe A. B. Vanderlei, Dorival de Carlucci, Renato N. Gotoda, Flávio C. Hojaij, Vergilius J. F. Araújo-Filho
    Current Oncology Reports.2022; 24(1): 69.     CrossRef
  • Active Surveillance Versus Thyroid Surgery for Differentiated Thyroid Cancer: A Systematic Review
    Roger Chou, Tracy Dana, Megan Haymart, Angela M. Leung, Ralph P. Tufano, Julie Ann Sosa, Matthew D. Ringel
    Thyroid.2022; 32(4): 351.     CrossRef
  • A Review of Active Surveillance of Papillary Thyroid Microcarcinoma
    Cho Rok Lee
    Journal of Endocrine Surgery.2022; 22(1): 1.     CrossRef
  • Active Surveillance Versus Immediate Surgery for Low-Risk Papillary Thyroid Microcarcinoma Patients in South Korea: A Cost-Minimization Analysis from the MAeSTro Study
    Kyungsik Kim, June Young Choi, Su-jin Kim, Eun Kyung Lee, Young Ki Lee, Jun Sun Ryu, Kyu Eun Lee, Jae Hoon Moon, Young Joo Park, Sun Wook Cho, Sue K. Park
    Thyroid.2022; 32(6): 648.     CrossRef
  • A cross-sectional survey of patient treatment choice in a multicenter prospective cohort study on active surveillance of papillary thyroid microcarcinoma (MAeSTro)
    Yul Hwangbo, June Young Choi, Eun Kyung Lee, Chang Hwan Ryu, Sun Wook Cho, Eun Jae Chung, Jeong Hun Hah, Woo-Jin Jeong, Sue K. Park, Yuh-Seog Jung, Ji-hoon Kim, Min Joo Kim, Su-jin Kim, Yeo Koon Kim, Chang Yoon Lee, Ji Ye Lee, You Jin Lee, Hyeong Won Yu,
    Thyroid.2022;[Epub]     CrossRef
  • Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea
    Eun Kyung Lee, Jae Hoon Moon, Yul Hwangbo, Chang Hwan Ryu, Sun Wook Cho, June Young Choi, Eun-Jae Chung, Woo-Jin Jeong, Yuh-Seog Jung, Junsun Ryu, Su-jin Kim, Min Joo Kim, Yeo Koon Kim, Chang Yoon Lee, Ji Ye Lee, Hyeong Won Yu, Jeong Hun Hah, Kyu Eun Lee,
    Thyroid.2022; 32(11): 1328.     CrossRef
  • Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma
    Iwao Sugitani, Yasuhiro Ito, Dai Takeuchi, Hirotaka Nakayama, Chie Masaki, Hisakazu Shindo, Masanori Teshima, Kazuhiko Horiguchi, Yusaku Yoshida, Toshiharu Kanai, Mitsuyoshi Hirokawa, Kiyomi Y. Hames, Isao Tabei, Akira Miyauchi
    Thyroid.2021; 31(2): 183.     CrossRef
  • Effect of Initial Treatment Choice on 2-year Quality of Life in Patients with Low-risk Papillary Thyroid Microcarcinoma
    Jae Hoon Moon, Chang Hwan Ryu, Sun Wook Cho, June Young Choi, Eun-Jae Chung, Jeong Hun Hah, Yul Hwangbo, Woo-Jin Jeong, Yuh-Seog Jung, Ji-hoon Kim, Min Joo Kim, Su-jin Kim, Yeo Koon Kim, Chang Yoon Lee, Eun Kyung Lee, Ji Ye Lee, Kyu Eun Lee, You Jin Lee,
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(3): 724.     CrossRef
  • Adoption of Active Surveillance for Very Low-Risk Differentiated Thyroid Cancer in the United States: A National Survey
    Susan C Pitt, Nan Yang, Megan C Saucke, Nicholas Marka, Bret Hanlon, Kristin L Long, Alexandria D McDow, J P Brito, Benjamin R Roman
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(4): 1728.     CrossRef
  • Protocol for a Korean Multicenter Prospective Cohort Study of Active Surveillance or Surgery (KoMPASS) in Papillary Thyroid Microcarcinoma
    Min Ji Jeon, Yea Eun Kang, Jae Hoon Moon, Dong Jun Lim, Chang Yoon Lee, Yong Sang Lee, Sun Wook Kim, Min-Hee Kim, Bo Hyun Kim, Ho-Cheol Kang, Minho Shong, Sun Wook Cho, Won Bae Kim
    Endocrinology and Metabolism.2021; 36(2): 359.     CrossRef
  • Multifocality and Progression of Papillary Thyroid Microcarcinoma During Active Surveillance
    Ryuta Nagaoka, Aya Ebina, Kazuhisa Toda, Tomoo Jikuzono, Marie Saitou, Masaomi Sen, Hiroko Kazusaka, Mami Matsui, Keiko Yamada, Hiroki Mitani, Iwao Sugitani
    World Journal of Surgery.2021; 45(9): 2769.     CrossRef
  • Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
    Min Ji Jeon, Won Gu Kim, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    Endocrinology and Metabolism.2021; 36(4): 717.     CrossRef
  • The Concept of Economic Evaluation and Its Application in Thyroid Cancer Research
    Kyungsik Kim, Mijin Kim, Woojin Lim, Bo Hyun Kim, Sue K. Park
    Endocrinology and Metabolism.2021; 36(4): 725.     CrossRef
  • Genomic and Transcriptomic Characteristics According to Size of Papillary Thyroid Microcarcinoma
    Young Shin Song, Byung-Hee Kang, Seungbok Lee, Seong-Keun Yoo, Young Sik Choi, Jungsun Park, Dong Yoon Park, Kyu Eun Lee, Jeong-Sun Seo, Young Joo Park
    Cancers.2020; 12(5): 1345.     CrossRef
  • Experience with Active Surveillance of Thyroid Low-Risk Carcinoma in a Developing Country
    Alvaro Sanabria
    Thyroid.2020; 30(7): 985.     CrossRef
  • Association of Patient Age With Progression of Low-risk Papillary Thyroid Carcinoma Under Active Surveillance
    Alexandra Koshkina, Rouhi Fazelzad, Iwao Sugitani, Akira Miyauchi, Lehana Thabane, David P. Goldstein, Sangeet Ghai, Anna M. Sawka
    JAMA Otolaryngology–Head & Neck Surgery.2020; 146(6): 552.     CrossRef
  • Active surveillance in low risk papillary thyroid carcinoma
    Fabian Pitoia, Anabella Smulever
    World Journal of Clinical Oncology.2020; 11(6): 320.     CrossRef
  • Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival
    Jolanta Krajewska, Aleksandra Kukulska, Malgorzata Oczko-Wojciechowska, Agnieszka Kotecka-Blicharz, Katarzyna Drosik-Rutowicz, Malgorzata Haras-Gil, Barbara Jarzab, Daria Handkiewicz-Junak
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • The dilemma of papillary thyroid microcarcinoma management. To operate or not to operate, that is the question
    Juan C Galofré
    Endocrinología, Diabetes y Nutrición.2019; 66(8): 469.     CrossRef
  • Computed Tomography for Detecting Cervical Lymph Node Metastasis in Patients Who Have Papillary Thyroid Microcarcinoma with Tumor Characteristics Appropriate for Active Surveillance
    Dong-Hwa Lee, Yeo Koon Kim, Hyeong Won Yu, June Young Choi, So Yeon Park, Jae Hoon Moon
    Thyroid.2019; 29(11): 1653.     CrossRef
  • The dilemma of papillary thyroid microcarcinoma management. To operate or not to operate, that is the question
    Juan C Galofré
    Endocrinología, Diabetes y Nutrición (English ed.).2019; 66(8): 469.     CrossRef
  • Longitudinal Assessment of Quality of Life According to Treatment Options in Low-Risk Papillary Thyroid Microcarcinoma Patients: Active Surveillance or Immediate Surgery (Interim Analysis of MAeSTro)
    Sung Hye Kong, Junsun Ryu, Min Joo Kim, Sun Wook Cho, Young Shin Song, Ka Hee Yi, Do Joon Park, Yul Hwangbo, You Jin Lee, Kyu Eun Lee, Su-jin Kim, Woo-Jin Jeong, Eun-Jae Chung, Jeong Hun Hah, June Young Choi, Chang Hwan Ryu, Yuh-Seog Jung, Jae Hoon Moon,
    Thyroid.2019; 29(8): 1089.     CrossRef
  • Ultrasound-guided percutaneous laser ablation for papillary thyroid microcarcinoma: a retrospective analysis of 37 patients
    Lili Ji, Qin Wu, Jun Gu, Xuedong Deng, Wei Zhou, Xing Fan, Feng Zhou
    Cancer Imaging.2019;[Epub]     CrossRef
  • Evolving management considerations in active surveillance for micropapillary thyroid carcinoma
    Allen S. Ho, Irene Chen, Michelle Melany, Wendy L. Sacks
    Current Opinion in Endocrinology, Diabetes & Obesity.2018; 25(5): 353.     CrossRef
Close layer
Thyroid
Star-Shaped Intense Uptake of 131I on Whole Body Scans Can Reflect Good Therapeutic Effects of Low-Dose Radioactive Iodine Treatment of 1.1 GBq
Sung Hye Kong, Jung Ah Lim, Young Shin Song, Shinje Moon, Ye An Kim, Min Joo Kim, Sun Wook Cho, Jae Hoon Moon, Ka Hee Yi, Do Joon Park, Bo Youn Cho, Young Joo Park
Endocrinol Metab. 2018;33(2):228-235.   Published online May 4, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.2.228
  • 8,876 View
  • 59 Download
  • 3 Web of Science
  • 3 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

After initial radioactive iodine (RAI) treatment in differentiated thyroid cancer patients, we sometimes observe a star-shaped region of intense uptake of 131I on whole body scans (WBSs), called a ‘star artifact.’ We evaluated the clinical implications of star artifacts on the success rate of remnant ablation and long-term prognosis.

Methods

Total 636 patients who received 131I dose of 1.1 GBq for the initial RAI therapy and who did not show distant metastasis at the time of diagnosis were retrospectively evaluated. A negative second WBS was used for evaluating the ablation efficacy of the RAI therapy. Among them, 235 patients (36.9%) showed a star artifact on their first WBS.

Results

In patients with first stimulated thyroglobulin (sTg) levels ≤2 ng/mL, patients with star artifacts had a higher rate of negative second WBS compared with those without star artifacts (77.8% vs. 63.9%, P=0.044), and showed significantly higher recurrence-free survival (P=0.043) during the median 8.0 years (range, 1.0 to 10.0) of follow-up. The 5- and 10-year recurrence rates (5YRR, 10YRR) were also significantly lower in patients with star artifacts compared with those without (0% vs. 4.9%, respectively, P=0.006 for 5YRR; 0% vs. 6.4%, respectively, P=0.005 for 10YRR). However, ablation success rate or recurrence-free survival was not different among patients whose first sTg levels >2 ng/mL regardless of star artifacts.

Conclusion

Therefore, star artifacts at initial RAI therapy imply a good ablation efficacy or a favorable long-term prognosis in patients with sTg levels ≤2 ng/mL.

Citations

Citations to this article as recorded by  
  • Prognostic value of star-shaped intense uptake of 131I in thyroid cancer patients
    Liu Xiao, Wen Jie Zhang, Yue Qi Wang, Lin Li
    Revista Española de Medicina Nuclear e Imagen Molecular (English Edition).2021; 40(1): 30.     CrossRef
  • Valores pronósticos de la captación en estrella de 131I en pacientes con cáncer diferenciado de tiroides
    L. Xiao, W.J. Zhang, Y.Q. Wang, L. Li
    Revista Española de Medicina Nuclear e Imagen Molecular.2021; 40(1): 30.     CrossRef
  • Comparison between planar and single-photon computed tomography images for radiation intensity quantification in iodine-131 scintigraphy
    Yusuke Iizuka, Tomohiro Katagiri, Minoru Inoue, Kiyonao Nakamura, Takashi Mizowaki
    Scientific Reports.2021;[Epub]     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP